Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): August 1, 2023
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization)(Commission File Number)(I.R.S. Employer Identification No.)
1750 Presidents Street,Reston,Virginia20190
(Address of principal executive office)(Zip Code)

 (571) 526-6000
(Registrants' telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common stock, par value $.0001 per shareLDOSNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 2.02.Results of Operations and Financial Condition.
On August 1, 2023, Leidos Holdings, Inc. (the "Company") issued a press release announcing its financial results for the second fiscal quarter ended June 30, 2023. A copy of the press release is furnished as Exhibit 99.1 to this report.
The Company’s management will discuss operations and financial results in an earnings conference call beginning at 8:00 a.m. eastern on August 1, 2023. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Investor Relations section of the Company’s web site (http://investors.leidos.com).
The information contained in Item 2.02 of this report and Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01.Financial Statements and Exhibits.

(i) Exhibits
Exhibit 99.1
Exhibit 104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL and contained in Exhibit 101.

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:August 1, 2023 By: /s/ Christopher R. Cage
   Christopher R. Cage
  Its: Executive Vice President and Chief Financial Officer

EX-99.1 2 ldos063023q2pressreleaseex.htm EX-99.1 Document

Leidos Holdings, Inc. Reports Second Quarter Fiscal Year 2023 Results

Revenues of $3.8 billion, up 7% year-over-year
Net Income of $210 million (5.5% margin); Adjusted EBITDA of $420 million (10.9% margin)
Diluted Earnings per Share of $1.50, or $1.80 on a non-GAAP basis
Cash Flows from Operations of $164 million; Free Cash Flow of $124 million
Net Bookings of $2.9 billion (book-to-bill ratio of 0.8)
RESTON, Va., August 1, 2023 – Leidos Holdings, Inc. (NYSE: LDOS), a FORTUNE 500® science and technology leader, today reported financial results for the second quarter of fiscal year 2023.
Thomas Bell, Leidos Chief Executive Officer, commented, "It is my honor to lead Leidos into its second decade of top-line growth, which we plan to complement with a sharper focus on earnings and cash through disciplined financial management. This focus is underscored by the strong second quarter results announced today, characterized by record revenues and adjusted EBITDA. Propelling our future performance, we will remain dedicated to resolving with pace the most challenging problems faced by our customers, our nation, and its allies—an approach that distinctly sets Leidos apart."
Summary Operating Results
Three Months Ended
(in millions, except margin and per share amounts)June 30, 2023July 1, 2022
Revenues$3,838 $3,597 
Net income$210 $172 
Net income margin5.5 %4.8 %
Diluted earnings per share (EPS)$1.50 $1.24 
Non-GAAP Measures*:
Adjusted EBITDA$420 $366 
Adjusted EBITDA margin10.9 %10.2 %
Non-GAAP diluted EPS$1.80 $1.59 
* Non-GAAP financial measures should be considered in addition to, but not as a substitute for, the information provided in accordance with GAAP. Management believes that these non-GAAP measures provide another measure of Leidos' results of operations and financial condition, including its ability to comply with financial covenants. See Non-GAAP Financial Measures at the end of this press release for more information and a reconciliation of our selected reported results to these non-GAAP measures.
Revenues for the quarter were $3.84 billion, up 7% compared to the second quarter of 2022. Revenues grew year-over-year primarily due to increased demand across all customer segments, especially for digital modernization, hypersonics, and medical examinations solutions.
Net income was $210 million and diluted EPS was $1.50. Net income and diluted EPS were up 22% and 21% year-over-year, respectively. Adjusted EBITDA was $420 million for the second quarter, up 15% year-over-year. Adjusted EBITDA margin of 10.9% increased from 10.2% in the second quarter of 2022. Non-GAAP net income was $252 million for the second quarter, up 15% year-over-year, and non-GAAP diluted EPS for the quarter was $1.80, up 13% year-over-year.
The primary drivers of increased earnings were improved business mix and program execution within each segment as well as reduced indirect spending across the company.


Cash Flow Summary
In the second quarter Leidos generated $164 million of net cash provided by operating activities and used $44 million in investing activities and $164 million in financing activities. Net cash provided by operating activities benefited from strong collections and working capital management. Days Sales Outstanding (DSO) for the quarter was 59, a 3-day improvement from the first quarter of 2023.
Investing activities consisted primarily of $40 million in property, equipment and software payments, which resulted in quarterly free cash flow of $124 million. Financing activities were driven by the payment of the remaining $320 million of principal on the 364-day term loan credit agreement from May 6, 2022, netted against borrowings of $200 million of commercial paper notes. In addition, Leidos returned $50 million to shareholders in the second quarter as part of its regular quarterly cash dividend program. As of June 30, 2023, Leidos had $329 million in cash and cash equivalents and $4.9 billion of debt.
On July 28, 2023, the Leidos Board of Directors declared a cash dividend of $0.36 per share to be paid on September 29, 2023, to stockholders of record at the close of business on September 15, 2023.
Business Development
Net bookings totaled $2.9 billion in the quarter, representing a book-to-bill ratio of 0.8. As a result, backlog at the end of the quarter was $34.2 billion, of which $8.3 billion was funded. Included in the quarterly bookings were several notable awards:
Common Hypersonics Glide Body (CHGB) Follow-On. The U.S. Army Program Executive Office Missiles and Space (PEO MS) awarded Leidos a four-year, $428 million prime contract to develop and test new CHGB prototypes. Under this follow-on, the Dynetics team expects to build up to 31 new CHGB prototypes to support Army and Navy requirements.
Centers for Medicare and Medicaid Services (CMS) Office of Information Technology End-User Centric IT Support. The CMS OIT awarded Leidos a contract with a total estimated value of $197 million over five years to provide seat-management services for CMS OIT employees and contractors and their personal computers, mobile devices and productivity services enabled through those devices. Under the contract, Leidos will continue to deliver engineering, innovation and accessibility compliance support to an onsite and remote workforce with a focus on fostering a positive end-user experience.
Royal Saudi Air Force (RSAF) Contractor Engineering & Technical Services Follow-On (CETS V). The RSAF awarded Leidos a contract with a total estimated value of $105 million over four years to maintain and enhance RSAF Command, Control, Communications, Computers and Intelligence (C4I) systems, including ground communications, radars, and IT systems, and support various aircraft platforms and systems support programs.
Defense Enclave Services (DES) DoDNet Planning and Design (DPAD). The Defense Information Systems Agency (DISA) awarded Leidos a DES task order with a total estimated value of $69 million over 55 months to migrate 14 Defense Agencies and Field Activities (DAFAs) to DoDNet. This award is the second task order under the DES effort to consolidate enterprise IT services and provide standardized, responsive and cost-effective solutions for more than 370,000 users spanning 22 Department of Defense (DoD) agencies and field activities with over 500 sites both in the U.S. and abroad. The work will focus on mission value and user experience, while improving cybersecurity, network availability and reliability.
In addition, Leidos expanded its partnership network in support of technology offerings. As part of a Trusted Generative AI campaign, Leidos strengthened its collaboration with industry leaders, harnessing shared expertise to drive innovation in AI. These partnerships allow Leidos to work with the most advanced models available—from OpenAI's GPT-4 through Microsoft to Google's Bard and Amazon's Bedrock. This collaboration enables secure environments that protect sensitive data while leveraging the power of Generative AI. In addition, Leidos and Aalyria have partnered to integrate Aalyria's Spacetime networking technology with Leidos' global-scale network management and protection solutions for critical government missions. By integrating Spacetime into new and existing solutions, the companies are developing multi-domain mission infrastructure capabilities that are secure, resilient and capable of spanning air, land, sea and space.

Forward Guidance
Leidos is updating its fiscal year 2023 guidance as follows:
FY23 Guidance
Revenues (billions)$14.9 - $15.2$14.7 - $15.1
Adjusted EBITDA Margin10.1% - 10.5%10.3% - 10.5%
Non-GAAP Diluted EPS$6.40 - $6.80$6.40 - $6.80
Cash Flows Provided by Operating Activities (millions)at or above $700at or above $700
For information regarding adjusted EBITDA margin and non-GAAP diluted EPS, see the related explanations and reconciliations to GAAP measures included elsewhere in this release.
Leidos does not provide a reconciliation of forward-looking adjusted EBITDA margins or non-GAAP diluted EPS to net income due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. Because certain deductions for non-GAAP exclusions used to calculate projected net income may vary significantly based on actual events, Leidos is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income at this time. The amounts of these deductions may be material and, therefore, could result in projected net income and diluted EPS being materially less than what may be implied by projected adjusted EBITDA margins and non-GAAP diluted EPS.
Conference Call Information
Leidos management will discuss operations and financial results in an earnings conference call beginning at 8:00 A.M. eastern time on August 1, 2023. Analysts and institutional investors may participate by dialing +1 (877) 869-3847 (toll-free U.S.) or +1 (201) 689-8261 (international callers).
A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Leidos Investor Relations website (http://ir.leidos.com).
After the call concludes, an audio replay can be accessed on the Leidos Investor Relations website or by dialing +1 (877) 660-6853 (toll-free U.S.) or +1 (201) 612-7415 (international callers) and entering conference ID 13739546.
About Leidos
Leidos is a Fortune 500® technology, engineering, and science solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, civil and health markets. Leidos' 46,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Va., Leidos reported annual revenues of approximately $14.4 billion for the fiscal year ended December 30, 2022.
For more information, visit www.leidos.com.


Forward-Looking Statements
Certain statements in this release contain or are based on "forward-looking" information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as "expects," "intends," "plans," "anticipates," "believes," "estimates," "guidance" and similar words or phrases. Forward-looking statements in this release include, among others, estimates of our future growth, strategy and financial and operating performance, including future revenues, adjusted EBITDA margins, diluted EPS (including on a non-GAAP basis) and cash flows provided by operating activities, as well as statements about our business contingency plans, government budgets and the ongoing Continuing Resolution, uncertainties in tax due to new tax legislation or other regulatory developments, strategy, planned investments, sustainability goals and our future dividends, share repurchases, capital expenditures, debt repayments, acquisitions, dispositions and cash flow conversion. These statements reflect our belief and assumptions as to future events that may not prove to be accurate.
Actual performance and results may differ materially from those results anticipated by our guidance and other forward-looking statements made in this release depending on a variety of factors, including, but not limited to: developments in the U.S. government defense and non-defense budgets, including budget reductions, sequestration, implementation of spending limits or changes in budgetary priorities, delays in the U.S. government budget process or a government shutdown, or the U.S. government’s failure to raise the debt ceiling, which increases the possibility of a default by the U.S. government on its debt obligations, related credit-rating downgrades, or an economic recession; uncertainties in tax due to new tax legislation or other regulatory developments; rising inflationary pressures and fluctuations in interest rates; delays in the U.S. government contract procurement process or the award of contracts and delays or loss of contracts as a result of competitor protests; changes in U.S. government procurement rules, regulations and practices; our compliance with various U.S. government and other government procurement rules and regulations; governmental reviews, audits and investigations of our company; our ability to effectively compete and win contracts with the U.S. government and other customers; our ability to respond rapidly to emerging technology trends, including the use of artificial intelligence; our reliance on information technology spending by hospitals/healthcare organizations; our reliance on infrastructure investments by industrial and natural resources organizations; energy efficiency and alternative energy sourcing investments; investments by U.S. government and commercial organizations in environmental impact and remediation projects; the effects of health epidemics, pandemics and similar outbreaks may have on our business, financial position, results of operations and/or cash flows; our ability to attract, train and retain skilled employees, including our management team, and to obtain security clearances for our employees; our ability to accurately estimate costs, including cost increases due to inflation, associated with our firm-fixed-price contracts and other contracts; resolution of legal and other disputes with our customers and others or legal or regulatory compliance issues; cybersecurity, data security or other security threats, system failures or other disruptions of our business; our compliance with international, federal, state and local laws and regulations regarding privacy, data security, protection, storage, retention, transfer and disposal, technology protection and personal information; the damage and disruption to our business resulting from natural disasters and the effects of climate change; our ability to effectively acquire businesses and make investments; our ability to maintain relationships with prime contractors, subcontractors and joint venture partners; our ability to manage performance and other risks related to customer contracts; the failure of our inspection or detection systems to detect threats; the adequacy of our insurance programs, customer indemnifications or other liability protections designed to protect us from significant product or other liability claims, including cybersecurity attacks; our ability to manage risks associated with our international business; our ability to comply with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act of 2010 and similar worldwide anti-corruption and anti-bribery laws and regulations; our ability to protect our intellectual property and other proprietary rights by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our ability to prevail in litigation brought by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our ability to declare or increase future dividends based on our earnings, financial condition, capital requirements and other factors, including compliance with applicable law and our agreements; our ability to grow our commercial health and infrastructure businesses, which could be negatively affected by budgetary constraints faced by hospitals and by developers of energy and infrastructure projects; our ability to successfully integrate acquired businesses; and our ability to execute our business plan and long-term management initiatives effectively and to overcome these and other known and unknown risks that we face.

These are only some of the factors that may affect the forward-looking statements contained in this release. For further information concerning risks and uncertainties associated with our business, please refer to the filings we make from time to time with the U.S. Securities and Exchange Commission ("SEC"), including the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Legal Proceedings" sections of our latest Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, all of which may be viewed or obtained through the Investor Relations section of our website at www.leidos.com.
All information in this release is as of August 1, 2023. Leidos expressly disclaims any duty to update the guidance or any other forward-looking statement provided in this release to reflect subsequent events, actual results or changes in Leidos' expectations. Leidos also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.

Investor Relations:Media Relations:
Stuart DavisMelissa Lee Dueñas

(in millions, except per share amounts)
Three Months EndedSix Months Ended
 June 30,
July 1,
June 30,
July 1,
Revenues$3,838 $3,597 $7,537 $7,091 
Cost of revenues3,271 3,059 6,475 6,041 
Selling, general and administrative expenses237 262 470 498 
Acquisition, integration and restructuring costs6 9 
Asset impairment charges  
Equity earnings of non-consolidated subsidiaries(7)(3)(13)(1)
Operating income331 271 596 542 
Non-operating expense:
Interest expense, net(56)(50)(110)(98)
Other (expense) income, net(1)(5)
Income before income taxes274 225 481 447 
Income tax expense(64)(53)(107)(98)
Net income210 172 374 349 
Less: net income attributable to non-controlling interest3 5 
Net income attributable to Leidos common stockholders$207 $171 $369 $346 
Earnings per share:
Basic$1.51 $1.25 $2.69 $2.51 
Diluted1.50 1.24 2.67 2.49 
Weighted average number of common shares outstanding:
Basic137 137 137 138
138 138 138 139
Cash dividends declared per share$0.36 $0.36 $0.72 $0.72 


(in millions, except par value)
June 30,
December 30,
Cash and cash equivalents$329 $516 
Receivables, net2,478 2,350 
Inventory, net310 287 
Other current assets459 490 
Total current assets3,576 3,643 
Property, plant and equipment, net928 847 
Intangible assets, net851 952 
Goodwill6,701 6,696 
Operating lease right-of-use assets, net534 545 
Other long-term assets436 388 
Total assets$13,026 $13,071 
Accounts payable and accrued liabilities$1,970 $2,254 
Accrued payroll and employee benefits666 701 
Short-term debt and current portion of long-term debt219 992 
Total current liabilities2,855 3,947 
Long-term debt, net of current portion4,670 3,928 
Operating lease liabilities553 570 
Deferred tax liabilities16 40 
Other long-term liabilities279 233 
Total liabilities8,373 8,718 
Stockholders’ equity:  
Common stock, $0.0001 par value, 500 million shares authorized, 137 million and 137 million shares issued and outstanding at June 30, 2023, and December 30, 2022, respectively
Additional paid-in capital2,024 2,005 
Retained earnings2,636 2,367 
Accumulated other comprehensive loss(63)(73)
Total Leidos stockholders’ equity4,597 4,299 
Non-controlling interest56 54 
Total stockholders' equity4,653 4,353 
Total liabilities and stockholders' equity$13,026 $13,071 

(in millions)
Three Months EndedSix Months Ended
 June 30,
July 1,
June 30,
July 1,
Cash flows from operations:
Net income$210 $172 $374 $349 
Adjustments to reconcile net income to net cash provided by operations:
Depreciation and amortization84 83 166 168 
Stock-based compensation19 19 37 35 
Deferred income taxes(45)(75)(88)(136)
Other1 6 
Change in assets and liabilities, net of effects of acquisitions and dispositions:
Receivables43 (6)(123)(238)
Other current assets and other long-term assets58 101 49 73 
Accounts payable and accrued liabilities and other long-term liabilities(101)(206)(198)(266)
Accrued payroll and employee benefits(45)(23)(32)101 
Income taxes receivable/payable(60)(23)(125)45 
Net cash provided by operating activities164 45 66 138 
Cash flows from investing activities:
Acquisition of a business, net of cash acquired(4)— (4)(2)
Divestiture of a business
Payments for property, equipment and software(40)(21)(79)(49)
Net proceeds from sale of assets  
Net cash used in investing activities(44)(8)(83)(29)
Cash flows from financing activities:
Proceeds from debt issuance 380 1,743 380 
Net proceeds from commercial paper200 75 200 150 
Repayments of borrowings(325)(407)(2,036)(434)
Payments for debt issuance costs — (7)— 
Dividend payments(50)(49)(100)(100)
Repurchases of stock and other (2)(43)(528)
Proceeds from issuances of stock13 10 25 22 
Net capital distributions to non-controlling interests(2)(1)(3)(3)
Net cash (used in) provided by financing activities(164)(221)(513)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash1 (5)3 (5)
Net (decrease) increase in cash, cash equivalents and restricted cash(43)38 (235)(409)
Cash, cash equivalents and restricted cash at beginning of period491 428 683 875 
Cash, cash equivalents and restricted cash at end of period448 466 448 466 
Less: restricted cash at end of period119 127 119 127 
Cash and cash equivalents at end of period$329 $339 $329 $339 

(in millions)

Three Months EndedSix Months Ended
June 30,
July 1,
June 30,
July 1,
Defense Solutions$2,187$2,052$4,299$4,101
Operating income (loss):
Defense Solutions$175$139$322$272
Operating income margin:
Defense Solutions8.0 %6.8 %7.5 %6.6 %
Civil7.1 %4.4 %5.8 %4.9 %
Health16.3 %18.3 %15.7 %18.2 %
Total8.6 %7.5 %7.9 %7.6 %
Defense Solutions
Defense Solutions revenues of $2.19 billion increased by 7% compared to the prior year quarter. Revenue growth was primarily in the areas of digital modernization, including the Navy Next Generation Enterprise Network Recompete (NGEN-R) Service Management, Integration and Transport (SMIT) contract, and hypersonics, including the Space Defense Agency (SDA) Wide Field of View (WFOV) programs. For the quarter Defense Solutions operating income margin increased to 8.0% from 6.8% in the prior year quarter, and non-GAAP operating income margin increased to 9.3% from 8.3% in the prior year quarter. The increase in segment profitability was attributable to improved business mix and program execution as well as lower indirect spending.
Civil revenues of $902 million increased by 5% compared to the prior year quarter. The primary drivers of revenue growth were the National Aeronautics and Space Administration (NASA) Advanced Enterprise Global Information Technology Solutions (AEGIS) program, increased demand for engineering support to commercial energy companies, and a partial recovery within the security products portfolio. Civil operating income margin for the quarter was 7.1%, compared to 4.4% in the prior year quarter, and non-GAAP operating income margin was 9.1%, compared to 6.5% in the prior year quarter. In addition to improvements from business mix, program execution, and cost control, year-over-year segment profitability increased as a result of an adverse arbitration ruling and associated legal fees totaling $17 million in the second quarter of 2022.
Health revenues of $749 million increased by 9% compared to the prior year quarter driven by growth on the Social Security Administration (SSA) Information Technology Support Services Contract II (ITSSC II) and higher levels of medical examinations, based on increased volumes, greater market share, and new wins. Health operating income margin for the quarter was 16.3%, compared to 18.3% in the prior year quarter, and non-GAAP operating margin was 17.0%, compared to 19.8% in the prior year quarter. The decrease in segment profitability was driven primarily by the $28 million equitable adjustment in the second quarter of 2022 to cover costs incurred as a result of the COVID-19 pandemic.


(in millions)
Backlog represents the estimated amount of future revenues to be recognized under negotiated contracts. Backlog value is based on management’s estimates about volume of services, availability of customer funding and other factors, and excludes contracts that are under protest. Estimated backlog comprises both funded and negotiated unfunded backlog. Backlog estimates are subject to change and may be affected by several factors, including modifications of contracts, non-exercise of options and foreign currency movements.
Funded backlog for contracts with the U.S. government represents the value on contracts for which funding is appropriated less revenues previously recognized on these contracts. Funded backlog for contracts with non-U.S. government entities and commercial customers represents the estimated value on contracts, which may cover multiple future years, under which Leidos is obligated to perform, less revenue previously recognized on the contracts.
Negotiated unfunded backlog represents estimated amounts of revenue to be earned in the future from contracts for which funding has not been appropriated and unexercised priced contract options. Negotiated unfunded backlog does not include unexercised option periods and future potential task orders expected to be awarded under IDIQ, General Services Administration Schedule or other master agreement contract vehicles, with the exception of certain IDIQ contracts where task orders are not competitively awarded or separately priced but instead are used as a funding mechanism, and where there is a basis for estimating future revenues and funding on future anticipated task orders.
The estimated value of backlog as of the dates presented was as follows:
June 30, 2023July 1, 2022
Defense Solutions$4,904 $13,500 $18,404 $4,351 $13,668 $18,019 
Civil2,134 7,710 9,844 2,051 8,846 10,897 
Health1,233 4,671 5,904 1,139 4,667 5,806 
Total$8,271 $25,881 $34,152 $7,541 $27,181 $34,722 
Total backlog as of June 30, 2023, as compared to July 1, 2022, included $610 million of backlog acquired through a business combination in the Defense Solutions reportable segment.

Leidos uses and refers to organic revenue, non-GAAP operating income, non-GAAP operating margin, adjusted EBITDA, adjusted EBITDA margin, non-GAAP diluted EPS, non-GAAP free cash flow and non-GAAP free cash flow conversion, which are not measures of financial performance under generally accepted accounting principles in the U.S. and, accordingly, these measures should not be considered in isolation or as a substitute for the comparable GAAP measures and should be read in conjunction with Leidos's consolidated financial statements prepared in accordance with GAAP.
Management believes that these non-GAAP measures provide another representation of the results of operations and financial condition, including its ability to comply with financial covenants. These non-GAAP measures are frequently used by financial analysts covering Leidos and its peers. The computation of non-GAAP measures may not be comparable to similarly titled measures reported by other companies, thus limiting their use for comparability.
Organic revenues capture the revenue that is inherent in the underlying business excluding the impact of acquisitions and divestitures made within the prior year; it is computed as current revenues excluding revenues from acquisitions within the last 12 months and divestitures within the current and year-ago periods.
Non-GAAP operating income is computed by excluding the following discrete items from operating income:
Acquisition, integration and restructuring costs – Represents acquisition, integration, lease termination, severance and retention costs related to acquisitions.
Amortization of acquired intangible assets – Represents the amortization of the fair value of the acquired intangible assets.
Asset impairment charges – Represents impairments of long-lived intangible assets.
Non-GAAP operating margin is computed by dividing non-GAAP operating income by revenues.
Adjusted EBITDA is computed by excluding the following items from income before income taxes: (i) discrete items as identified above; (ii) interest expense; (iii) interest income; (iv) depreciation expense; and (v) amortization of internally developed intangible assets.
Adjusted EBITDA margin is computed by dividing adjusted EBITDA by revenues.
Non-GAAP net income is computed by excluding the discrete items listed under non-GAAP operating income and their related tax impacts.
Non-GAAP diluted EPS is computed by dividing net income attributable to Leidos common stockholders, adjusted for the discrete items as identified above and the related tax impacts, by the diluted weighted average number of common shares outstanding.
Non-GAAP free cash flow is computed by deducting expenditures for property, equipment and software from net cash provided by operating activities.
Non-GAAP free cash flow conversion is computed by dividing non-GAAP free cash flow by non-GAAP net income attributable to Leidos common stockholders; operating cash flow conversion is computed by dividing net cash provided by operating activities by net income attributable to Leidos shareholders.


(in millions, except growth percentages)
The following table presents the reconciliation of revenues to organic revenues by reportable segment and total operations:
Three Months Ended
June 30,
July 1,
Percent Change
Defense Solutions
Revenues, as reported$2,187 $2,052 %
Acquisition revenues(1)
28 — 
Organic revenues$2,159 $2,052 %
Revenues, as reported$902 $857 %
Revenues, as reported$749 $688 %
Total Operations 
Revenues, as reported$3,838 $3,597 %
Acquisition revenues(1)
28 — 
Organic revenues$3,810 $3,597 %
(1) Current period acquisition revenues reflect revenues in the current as reported figures for 12 months from closing of each acquisition. For the three months ended June 30, 2023, Defense Solutions segment acquisition revenues include the acquisition of Cobham Special Missions that was completed on October 30, 2022.

(in millions, except per share amounts and margin percentages)

The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the three months ended June 30, 2023:

Three Months Ended June 30, 2023
As reportedAcquisition, integration and restructuring costsAmortization of acquired intangiblesNon-GAAP results
Operating income$331 $$51 $388 
Non-operating expense, net
(57)— — (57)
Income before income taxes
274 51 331 
Income tax expense(1)
Net income210 38 252 
Less: net income attributable to non-controlling interest
3 — — 3 
Net income attributable to Leidos common stockholders
$207 $$38 $249 
Diluted EPS attributable to Leidos common stockholders(2)
$1.50 $0.03 $0.28 $1.80 
Diluted shares138 138 138 138 
Three Months Ended June 30, 2023
As reportedAcquisition, integration and restructuring costsAmortization of acquired intangiblesNon-GAAP results
Net income$210$$38 $252
Income tax expense(1)
6413 79
Income before income taxes27451 331
Depreciation expense33— — 33
Amortization of intangibles51— (51)
Interest expense, net56— — 56
EBITDA$414$$— $420
EBITDA margin10.8 %10.9 %
(1) Calculation uses an estimated statutory tax rate on non-GAAP adjustments.
(2) Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.

(in millions, except per share amounts and margin percentages)

The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the three months ended July 1, 2022:

Three Months Ended July 1, 2022
As reportedAcquisition, integration and restructuring costsAmortization of acquired intangiblesAsset impairment chargesNon-GAAP results
Operating income$271 $$57 $$336 
Non-operating expense, net
(46)— — — (46)
Income before income taxes225 57 290 
Income tax expense(1)
Net income
172 42 220 
Less: net income attributable to non-controlling interest
— — — 
Net income attributable to Leidos common stockholders
$171 $$42 $$219 
Diluted EPS attributable to Leidos common stockholders(2)
$1.24 $0.03 $0.31 $0.01 $1.59 
Diluted shares138 138 138 138 138 
Three Months Ended July 1, 2022
As reportedAcquisition, integration and restructuring costsAmortization of acquired intangiblesAsset impairment chargesNon-GAAP results
Net income
$172$$42 $$220
Income tax expense(1)
5315 70
Income before income taxes22557 290
Depreciation expense26— — — 26
Amortization of intangibles57— (57)— 
Interest expense, net50— — — 50
EBITDA$358$$— $$366
EBITDA margin10.0 %10.2 %
(1) Calculation uses an estimated statutory tax rate on non-GAAP adjustments.
(2) Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.


(in millions, except per share amounts and margin percentages)

The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the six months ended June 30, 2023:
Six Months Ended June 30, 2023
As reportedAcquisition, integration and restructuring costsAmortization of acquired intangiblesNon-GAAP results
Operating income$596 $$103 $708 
Non-operating expense, net
(115)— — (115)
Income before income taxes
481 103 593 
Income tax expense(1)
Net income374 76 457 
Less: net income attributable to non-controlling interest
5 — — 5 
Net income attributable to Leidos common stockholders
$369 $$76 $452 
Diluted EPS attributable to Leidos common stockholders(2)
$2.67 $0.05 $0.55 $3.28 
Diluted shares138 138 138 138 

Six Months Ended June 30, 2023
As reportedAcquisition, integration and restructuring costsAmortization of acquired intangiblesNon-GAAP results
Net income$374$$76 $457
Income tax expense(1)
10727 136
Income before income taxes481103 593
Depreciation expense63— — 63
Amortization of intangibles103— (103)
Interest expense, net110— — 110
EBITDA$757$$— $766
EBITDA margin10.0 %10.2 %
(1) Calculation uses an estimated statutory tax rate on non-GAAP adjustments.
(2) Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.


(in millions, except per share amounts and margin percentages)

The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the six months ended July 1, 2022:

Six Months Ended July 1, 2022
As reportedAcquisition, integration and restructuring costsAmortization of acquired intangiblesAsset impairment chargesNon-GAAP results
Operating income$542 $$115 $$668 
Non-operating expense, net
(95)— — — (95)
Income before income taxes447 115 573 
Income tax expense(1)
Net income
349 86 443 
Less: net income attributable to non-controlling interest
— — — 
Net income attributable to Leidos common stockholders
$346 $$86 $$440 
Diluted EPS attributable to Leidos common stockholders (2)
$2.49 $0.04 $0.63 $0.01 $3.17 
Diluted shares139 139 139 139 139 

Six Months Ended July 1, 2022
As reportedAcquisition, integration and restructuring costsAmortization of acquired intangiblesAsset impairment chargesNon-GAAP results
Net income
$349$$86 $$443
Income tax expense(1)
9829 130
Income before income taxes447115 573
Depreciation expense52— — — 52
Amortization of intangibles116— (115)— 1
Interest expense, net98— — — 98
EBITDA$713$$— $$724
EBITDA margin10.1 %10.2 %
(1) Calculation uses an estimated statutory tax rate on non-GAAP adjustments.
(2) Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.

(in millions, except margin percentages)
The following tables present the reconciliation of non-GAAP operating income by reportable segment and Corporate to operating income:
Three Months Ended June 30, 2023
Operating income (loss)Acquisition, integration and restructuring costsAmortization of acquired intangiblesNon-GAAP operating income (loss)Non-GAAP operating margin
Defense Solutions$175 $— $29 $204 9.3 %
Civil64 17 82 9.1 %
Health122 — 127 17.0 %
Corporate(30)— (25)NM
Total$331 $$51 $388 10.1 %

Three Months Ended July 1, 2022
Operating income (loss)Acquisition, integration and restructuring costsAmortization of acquired intangiblesAsset Impairment ChargesNon-GAAP operating income (loss)Non-GAAP operating margin
Defense Solutions$139 $— $32 $— $171 8.3 %
Civil38 — 18 — 56 6.5 %
Health126 — 136 19.8 %
Corporate(32)— — (27)NM
Total$271 $$57 $$336 9.3 %

Six Months Ended June 30, 2023
Operating income (loss)Acquisition, integration and restructuring costsAmortization of acquired intangiblesNon-GAAP operating income (loss)Non-GAAP operating margin
Defense Solutions$322 $— $59 $381 8.9 %
Civil104 33 138 7.8 %
Health229 — 11 240 16.4 %
Corporate(59)— (51)NM
Total$596 $$103 $708 9.4 %

Six Months Ended July 1, 2022
Operating income (loss)Acquisition, integration and restructuring costsAmortization of acquired intangiblesAsset Impairment ChargesNon-GAAP operating income (loss)Non-GAAP operating margin
Defense Solutions$272 $— $65 $— $337 8.2 %
Civil81 — 36 — 117 7.1 %
Health244 — 14 261 19.5 %
Corporate(55)— — (47)NM
Total$542 $$115 $$668 9.4 %
NM - Not Meaningful

(in millions, except percentages)

The following table presents the reconciliation of non-GAAP free cash flow to net cash provided by operating activities as well as the calculation of operating cash flow and non-GAAP free cash flow conversion ratios:
Three Months Ended
June 30, 2023July 1, 2022
Net cash provided by operating activities(1)
$164 $45 
Payments for property, equipment and software(40)(21)
Non-GAAP free cash flow$124 $24 
Net income attributable to Leidos common stockholders
$207 $171 
Acquisition, integration and restructuring costs(2)
Amortization of acquired intangibles(2)
38 42 
Asset impairment charges(2)
Non-GAAP net income attributable to Leidos common stockholders$249 $219 
Operating cash flow conversion ratio79 %26 %
Non-GAAP free cash flow conversion ratio50 %11 %
(1) Prior year financial information has been reclassified to reflect the effect of foreign exchange rate changes on cash, cash equivalents and restricted cash in net cash provided by operating activities.
(2) After-tax expenses excluded from non-GAAP net income.
EX-101.SCH 3 ldos-20230801.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ldos-20230801_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Cover page. Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Type Document Type Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 5 ldos-20230801_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover Cover
Aug. 01, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Aug. 01, 2023
Entity Registrant Name LEIDOS HOLDINGS, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-33072
Entity Tax Identification Number 20-3562868
Entity Address, Address Line One 1750 Presidents Street,
Entity Address, City or Town Reston,
Entity Address, State or Province VA
Entity Address, Postal Zip Code 20190
City Area Code 571
Local Phone Number 526-6000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, par value $.0001 per share
Trading Symbol LDOS
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0001336920
Amendment Flag false
XML 7 ldos-20230801_htm.xml IDEA: XBRL DOCUMENT 0001336920 2023-08-01 2023-08-01 0001336920 false 8-K 2023-08-01 LEIDOS HOLDINGS, INC. DE 001-33072 20-3562868 1750 Presidents Street, Reston, VA 20190 571 526-6000 false false false false Common stock, par value $.0001 per share LDOS NYSE false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Cover Sheet http://www.leidos.com/role/CoverCover Cover Cover Cover 1 false false All Reports Book All Reports ldos-20230801.htm ldos-20230801.xsd ldos-20230801_lab.xml ldos-20230801_pre.xml ldos063023q2pressreleaseex.htm http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ldos-20230801.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "contextCount": 1, "dts": { "inline": { "local": [ "ldos-20230801.htm" ] }, "labelLink": { "local": [ "ldos-20230801_lab.xml" ] }, "presentationLink": { "local": [ "ldos-20230801_pre.xml" ] }, "schema": { "local": [ "ldos-20230801.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2023": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ldos", "nsuri": "http://www.leidos.com/20230801", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ldos-20230801.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover Cover", "menuCat": "Cover", "order": "1", "role": "http://www.leidos.com/role/CoverCover", "shortName": "Cover Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "ldos-20230801.htm", "contextRef": "c-1", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2023", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2023", "presentation": [ "http://www.leidos.com/role/CoverCover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 14 0001336920-23-000049-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001336920-23-000049-xbrl.zip M4$L#!!0 ( $(P 5?CX9KSP1 ,6! 1 ;&1OV19!V\9F M9#O _OJMDFW>DS@$R,NDOW3 LE0J53UZ2BJ)L[]/ACZY8R+B87"N&)JND+\W MS_ZBJK__H_N%? K=9,B"F+0$HS'SR)C' Q(/&/DM%-_Y'277/HW[H1BJJGRK M%8ZF@M\.8F+JII67RAZ*AFU0:E7J?=4LU\NJ[=9=E5I.374LIV)7&:O8IG5R MVW"87K;=&E6]J@?%3(>J==."LLSV;*]:,;QRY<1K&/6JTW=MV]!=U_9C1JDT'H^UB2-\+12W)1[X/ MX5(L:!!A?V@,"BE!)W15-U7#5+)*\"6^N1I3URVH*XIIX#)EWJ@:,7?I#?BL MW89W#[9KE%6]IEK&K-UHN=6QE;=IE'[_^J7G#MB0JBNM;WK#J-?KI0FJ):\: MA/C^0(_PL4.C68\F:^67:L:G>5&/S866E>8]AP>H6VNNI?L$,*P%-39D,258@\K^2/C=N=(*@Q@,5[V9CD!R-_UTKL1L$I=D MYTO-'W[XX2SFL<^:OA=&*LJCUW3CK)1^>59*JW9";]H\\_@=B>*IS\X5CT6."-9G@H%911OTC^/=B*3Y0:R1"%B9"?I LVLM[*OF!O\^^9U&?^B7OX MN<^9(+)^MM$16YU?E_6\^G(S_VJY]A&H*_3R3^!Z(OX$,-G$_J'[HC&M/IN) MZ=U3-'^2?\X;*2WU.U?23"NE!3LL@;6F)HO:X8_AY/^C]N;O9&8^Y($Z8(CE M#=O4JN51?#KF7CQH&+K^5T46;9Y%(PHVXH@25)#^G=:S7AL5MU"A$\9Q.&R8 M4!GV0J4^OPT:+JB5"26M+G_##?U0-'[4Y;_3/G1;[=,A]Z>-GV[X$&SQDHU) M-QS2X*>3"- 38%;P?EHPXO]A(">T(C^.LVY /0@E>;<,$SM"EB5?ESD.1PW[ M>0)?"$[]^\2LK8A9W2CFM\O.3?L3Z=U? M2/OWUB\7ES^W2>OJZ]=.K]>YNCRXX&8AP7^CT8 'MW$8G)!/6DL#]E*VZVO" M[D>DS6;YMQ^-BGZZ#WWMU'N6Q3R_-*(>0Z$5%"(52*0])C+M+X5%^& M14)!C/*1=TS"_BN5'D,ZD#H1/.8 #NV).P"6Q\B%&X/0Q*A;=I%ITGCFQ+Z# MGB!W0I&[;!2*F!SEG]L4V!.+8M*^PX V?,V(%J3 MN.'!-^H0JAC@:ZI'I^J44:&R8$:[E>9%JZ)@Z/LN5YH0" MJ)T*NO/I*&*-_(_3/!I)HR15OG2ZS+:0ND&('W.7^MG R#%*'\]9G::GS"X& M"AE[>^C/3U&K5RKV/=3E1]3S@%4T=&+(-_+V%E];*6J.)EAX MW8=6!S =N]UXEOFH9Z5V\<28MLMN>80+&_$E/,G-WU*:7]J=3U<]\LO5ET^= MRY][)Z1SV=+N\X("2EO2[^8Q,^Q-8[:M\H<0&_ML-\JO/S;U2MT?M2<4H!A5 MC& F9JHE-"+1B+D8IGJ$!X3'$0'P!FP3Q\_284E"2<&9ZK!85:]KM;*U%509 M6JVV>TRI:I6:O7L U.Q:,:!ZD@HTV[#V(*MEFSNOU:AI-6/WU>Y'6-/63*N8 M9C.06G9*8WWF>)'I8"T:V,UTT G<4 #IDBO965V/N MH2?2GS'.#2&2%.3?$$A&'I=1,/(5ONC[LIBXI0'_C_R\-4W9D:$=6E>M<#CD M$6ZX$G3(=)4@M9P_FRHZ6E?K::0]'/GA%.QFV9O(9:@=;_*3%7)O%>#V3]#6 M1]%- =46-B83 =X@K%]XGF!1E/WW!>HSYH2,Z6UX,\K<1..9\2MIC2[+,(=EL*:JA31E,_Z;]C&Y+QY):Z!YW*9 MMU&0!M>5YK\XQLV<'H:V[:?H.[3\ZQ"&S/\_/DK#FFRK244R#);UT MT:S8"<;H M?H*&32CH$92R""O/-.C#[)2DR0(#YGZ7*;B#'_%AXLR%T('> MTWR! Q\L;,HD4(\@-)CFS_JA#XWC>\CE. ;_4>.)#E7,I8MI:=FC#[Q[4]'L MNK'5[HU6K]__=-MU^[JMU8QBU6X?"^\L3"'? HZ^2;[VGK6C6!P#?Q,\!L_ M9:LDR)9FHO5(Q0E#WZ%@YC$XVPPG+;2U>M6V3W<;(&_2Y\Y6KXII,-,+"+ZH M&#):2 3J)N!7MEG. &$ERP:3:XZ,*FE][A+3TC4HN('(K9&*'0-&Y0,P/@!C MIX#1"WWN@HD'MU]A[D49BJ*%_7[18JX4,LRTL@X5ADV!6BZ@Q5(BW@PK;# Q M6?(#+C[@XLW#Q;5@R"WPK(],T482+J[Z?8RVBL%&^?W"!BA'=1>T\RC;,&Q/ M-8^$Y__1(.1N7-/>O-L)&I*\\NGJ]Z'EG=L\CES M3$^#K9)QQ)+E'">C#G #8>3_AN([Z:%3S,CGXVDT]\2O+[\_V0D\Y-N,.%/B MRKU*((/? 3Z9S)Q>V4CD$0&Y@*PC7[PEMR(\,)=GQD9X9@RSLU/N;SJJN:&N36>#9Y5B M'#!_;Z%:[:VQYJJM&49]]X>$#,VH57?.;TW-K!<[@%:0B#Z/K>P]\[=8O-O> M[#?/B^-WU[?#KY&DF8JY6GZ66FFE2BFX/&+JQ99'7CD(]Q^ 54R%V8C1?"W/ M8P (S'SFXM5X02B7#9*(R5(P EDV"5[MQN520GJ5$RI:MN5/L7%YI1ZB>0!S M'3P1[(Y'\![@.@U<-!/JNGA23@8>,0T\*KPHS2/Q[ENSL([H;,UB$; U0K9) MX]J!I6;KN9GEO%C"VW/OA%JY$6L4ID/;$,RGF.&Z=D?6?*J3LY8^?X4ZP/J2 M>/V5QZ[5>NKU7E4E?V<@Y@!WRU1',/I=I7U0=(/Z8SJ-E-(>[P!#5%%AA 5U MXT:4#,&IIGN[+:18AJ&\1DC> K0M&.TQT?+@5,DPS6VHDJ%KM3UFF]HJW&0IVJ,NBQ(_E(8 KF/.RW068ND$[@:.<+)6,GIUC'$=E$"\S>%J1Q/3, ,PBB0!QH$,-N[,BD5=#BG M 2+3*M('K K0%'0(!2(8:?)'(N_\("GI^&<29 =++3V52B,78$FC64;JIEI^V\_UDRC>AH! MCPM@XI-[7V/N^P3 TTWPN,JRF:XK'>)K9(P4= 0CBAP[NYZ4@/)]X@ G# *9 M/!V36D/7"=6&&I3'Q= UT"V_D0[3:"/7#&5\D M43(:^;(GF$@$8N)?DOS)CCE0ZQWEOIQ"Y #"D">.#_%!/!!A.MJA*+A MLTYPAZ?S(/:71 85$3%W,;UY595CYA!@,HP;6"ZTTG MB%%TF&+=D;)81#D^F=U#,(9 "AS%^3K M(=P);KNP47KSTR %'_A*XCD>56 Q*ADP L3-;H9RE^0&C;B#[!C#RRW+?7#- M%^::=4TWW@'7G#/*7NY[T2(P1=OSRV*']%:0/%.7BKII6(967D%W%2^XW;6& M9#T-#E2 NT6.@O'CO4R&3Q)C65,("*@7,ANW#V1ZK\ATSV)].NX9.,$P[ N; M'EK=V2U7U1_FJF=TX\H82Q5Q^D)BD?D/->@5"\*4/TS)+;)0D4VT03R4N800 M-W6S^-&3!&GY7MN3/,(%(K(Q(CXKT=4EPW=FQH9NOZ49]IZD)QF*@A $%XU) M7X3#- IH)4+,[U+&2#(_57N2;2;%60 A09G(GQ3"J7DINL@#"&.5CNQUJJ[O M\YVWN$F 5Y2\BEV"E]T0Z'5^OKRX^=9M/^VZ\Q<,W1Y&/2G\7P$XP,/PO3"88=!(-I'H,>*Y%R2%8 (F"48 M*LOJ:!(/0@&=\]971E[N9Q;>S$7K9)[S'/[:TLU=6?V5F'$1*48FT!@)"F'"$^VY=C;0H'A58!^D/&O&N>_*G&KYM#Q*] M$J_]\-@/CWVU9+(31Q^S_.O"B_;L*NE_<9?-[^&7^PJM 6?]A1S3*WG;M" % MMA7>V+I^*?U5>OE3]LW_ E!+ P04 " !", %7:ZPNWVL" !Z!P $0 M &QD;W,M,C R,S X,#$N>'-DS55;;]HP%'[G5WAYGG.'DJA0::TJ36(7=:W6 MM\F)3\!J8F>V*?3?SS;)(&U9A[2'\1"<<[[OW(]S?K%M:O0(4C'!9U[DAQX" M7@K*^'+FW=U>XZEW,1^-SM]A?/_A9H&N1+EN@&MT*8%HH&C#] KI%:#O0CZP M1X*^UD170C88SQWM4K1/DBU7&L5AG/2P7BOS-"(DF605CL?9&*=E5F*2%%-< M),4D/0.8I''R?ID7$([3.*-;E:MR!0U! M)C6N\JV:>2NMVSP(-IN-OTE\(9=!'(910I:*5J0FH$ZW!QG8"6AFGEV?W _M3]J4O@F MDA[RPL&P!58=& K4BWTF/5<_M8:K3 -JV-7F?TZ\E7!JXH:BS(7A&GUB_I9_ M:_2(T9EW*LHJ[FX_';A?G]P#?6^WM4J@89V[R0O>+$-Y_+C!RK-WS M/'C.>&9KK8!^X7-W?IYJ1^X@?R"6I"[7]>F\?5A':9VP+V6W:L%PUW;O!_OH M!+LEGX]^ 5!+ P04 " !", %73-PA0'0* !&7@ %0 &QD;W,M,C R M,S X,#%?;&%B+GAM;-5<76_;.!9][Z_09EYV@6$L411%%FT&W4P[*#;3!DV* M&>*?NB:,2DO7KS#P#^_/>7"^?75-PM5)([ MYYEBN9+.?9S?./F-I=D"@+/RLO/T]C&+9S>Y UWH;\PV M[V:OD<>8CVD$8$ #@ 05@/F< .YSC$*E,(+^S[/77+D!$H0!&4IM!CD#%/K: M5B&)9(@]&>#2Z3Q.OKTN_G"V5(X.+UF63]^>W.3Y[>O)Y/[^_O2!9_/3-)M- MH.OZDXWUR=K\8W$YK1;%,[ Q \5+P(/ ]TX?EO+D[)7CK.C(TKGZHB*G M^/_UR\?6(>FDL)@D:E9\MI*O>GBSCQ>U<;5Z[ MR534[':>936O!4I:H/1P@?*GML$F/> ?"&^^C?4 X,IP/QT*XRY./QT,[K7. M$.KX@"O#](:\NJ'>)W*H>_=IJ-[0CX_X4+=%FK/Y +?%\S 5R//BA0O]:#U, MX6A',BW'6:?N"E3UD*M$JE6VK+EV8OGV1#^:2A5/KY2XR^+\\?V#N&')3'UB M"S4-$:%4NA'PF/0 "I#4TY'P 8$*<0J%JSP\S9_NZ:E*P->KS?#E&+L'.#&( M+&]1:*:6Z5TFGN>VQ;QIPM)S53&[D4FBQUW>LO4%&F51"*R GVTP.AN03H'R MS>0Y'@L2YT>G9CXJ5E)10S(ORH T>QEZ*O:&_BRKI49=QKU4XG26?I_H2R=% MM54\ ,6#4DVM#B=;']N[;(.296(/QVN+B4AUA7.;@QK=498NNH63I]T^\15M M>M 3)\VDRG35VA! XWWG07X=YW,UE5JVF#!?%YDLU#6GBP$A;@@B$KH01SX* M?&HJW(WSL8FV!.6DD>/!?_)_.1NXYJI]8J^[8FTX.;):3>FPDNO+N'M)]9VQ8B7WZG'!T_G4%]B/9$A!X'+=KD(? X9\#KB>5P/DNZ[N8KLJ MLN9Y;')<@W-6Z+I+L4[7?AU:DW#L&K=;_$8";(S52GUU3X-)KS& JNZ:#^S-4\)EIHH^7FDOQ=F,C\OEGZG>GR$.2>"1LT0O[HP215=2K)+%7N>#)8RN85:31N=KS!/' MYC37TP&&7W5*F@8N9HBI"$ >Z1S!71\PR3F0G@LEAY1&I'-STCC"V%+$TZ&V M%4I'PW0*G-W30C.1^W-!;WJ.G ",F3$2_<[HK93>['$P>>\,J*KIW8;F0CY/ MOZOL'5_F&1/Y%)$PQ &D@$0>!4@H#)A@D7XJ(T]"&%&?=Q5PS?/8A%N"G3?S7X';KYW M!K?=>^\V[]UZ5SM!&%#F(2U_AOU YP J= [@!'A(18Q#3F%DVW3_G=KM@_39 MO3KLOTEO??2F^DCM]!@::;,6^C#-\U4ZCT6LYC-IQA+Y8;R:(V+%?=,L7+_UXL8Y9'K 1RZ7,N2ZZ98 M8:'_N*&$(:.!F>XAUXCJT-K;$G!L3OC;M&;]<4-H=JU MQ55'PW7%#?!K37'3^STWIR_39<[F?\6WY=W$"50D8@((*-QB1A2 !RP$+O*I M( 0'7!JVQ$W#C$V(+_=95V =C=;J=$LCLUT[XKY\#=,0&U-EOR'=R$3_[>BZ MVQ^S&=T86NM6=+.U_7[2M;YT"@E#0408(+XK 5*>GF:EP$#Y2&<"02*/&6\C M%8[')O&G/9("G/F64 JO";MGYJ M[YM+[9WV(0L_'^9L-O4#@2,M*N &/ 2(D@@P/:$"A75ERYC"O/L7&FN>QR:V M)W!.@:Z[VNIT[9>;-0E'UEO'^(T$UQBKE>+JG@:37&, 55VAJE M4\)T-$[3:O8ED5T+V1[T#%/#=F?&HGAMB;Y'W?K2X\ E:TM V]5JFZ&MD#_$ M\\V7[B0-&?-"!D*A='>*N)Y D1 @5%0@'C(<>IU7;E\Z'ZE\"X#&WU;<(JZK M9NWH&$:N79BP$.IVR#TT6G$VL#RWP]A69H--S\6C8D'J,M)(Q:[1.G6XEK-S&\%=97\ MVH81OSEC%@E@#QL]TD";YX&3P9X MU/"O@MZSOSK?Q=QHKPIEPPKB#W ,2]V MC6@(.,$,> $D"H<^5]+N"XW544::$)[FMO4#IP#K?$YL=XUJQ!K6 +9T#5P% M=&;*OA)H8J)_+5#S^F.J@:; 6NN!1F-;X7]1L[@XCIWDY2]">B%"4B@."",0 M(*_X^@)4#+!08.1Z(O"@82%0'V"D,E^ZL& #I, %0 &QD;W,M,C R,S X,#%?<')E+GAM;-6:VV[C M1A*&[_T46N5VVV*?F\;8@=>961CK9(P9!PER(_2A6B)"D4:3'MMOOT7:2JS8 MDQ"F '-N=*"*K.J_/G57%_GN^[M-.?L"J2GJZGA.#[/Y#"I?AZ):'<]_OOI MS/S[DX.#=_\BY-?_?+J8_5#[FPU4[>PL@6TAS&Z+=CUKUS#[I4Z_%U_L[+*T M;:S3AI"3_K2S^OH^%:MU.V,9XUNS[:_I2%!KNW7D()/"&TN"#FC&G"4YXV@+(HB@%0U2]1 MS]=M>WVT6-S>WA[>N50>UFFU8%G&%UOK^:/YW3/[6]Y;TSS/%_VO?Y@VQ4N& M>%FZ^/7'B\]^#1M+BJII;>4[!TUQU/0'+VIOVU[U?XQK]E6+[AO9FI'N$*&, M<'IXUX3YR<%L]B!'JDOX!''6O?_\Z7S'90E%J)M#7V\6W<^+LQIQZ%\PVO[L M]OX:CN=-L;DN87MLG2 >STL\DW1IS4S6^_SNR=F+/_U?)V@0FGZ\%WC@\2*= MOU?% GAKAU4M9^QZCL!*[_.+.T#LK^Z#) L>RO>NJ:-EG?+@WC #;G M)"H9B(#(B,FY(H(Z)E@NI0UL=^A=U V&W>>C 7^XJK\L\,*+3H[N0Z]+K\DS M=P_2O"[N[1_P"FV7S.84 M)C^K4X"$,\C6G4W^67IWV7VT6%S;A!0BCJ\K\(/./$N:?#11V!$.,UQ[%R3 M/ 1'I,N-]BPXJMQ>4K_C=A #;/H,O%[+-X;A?=46[?TG6!6=$E7[D]W T@5G MO&! $%J,7S!);&XBD<'*7'B%G(=1++SD=1 *?+HHC%9R$B2<8[&6KNO4"_\9 M]8>S^J9JT_U9'6 I.#W<>4*LB%@][D,>!@(Q.FH@+G^1 1!8,,5D,Q!NM<.LE%>A] M3!=?<3^("S5U+O:A[20@.0T!4] \ON&N#>B2Y8'RB#MT12F2;@4CN52&4$T5 MMY%YZ?4> 'G!]2 X]-3A&*OIE, XPX\?TU5]6RVM\3YRK;OH! M9HH:"AFC^UA"GCD>!(7Y1J!XI9Y30J*OBSZFRU1_*2H/2_25B:B!>*]S(G3$ M.<^@.$S0:+PVW-MQ796_\SX(COP;@6.,LE,BY+)N6EO^5ESW9;/D1GG0&#;K MFC!!.YSZ)$Y]UGFNP5K<@.V/CQW?PYI9V3>"Q^ME?6,XNDGO-('MXP:;!4<] M5L^.69S[M,"XG28\%Y13Z84,_N>Y27Z[K:;I^< MCKD4P6%1C.6Q4#HCCAE)@G-9Z.J?(,2HM/_5X[#43[B+.4K"-T[_+ZEH6ZC. MZLWFIGK<(C5+X95AE"JB.6 1;!@JX2WNDZ*VN080>52C&'C1[3 0)MS#'"_F M&]/PN2X+7[1%M?H1"YQ4V')IG&)Y!@I7+YEA\2LU,31ZPD+@E,:_/=;=VT\>(<2R5=MI*XXFDGA(A'4=!(B7. M2JLT%V #'P7#UWT/@V+"?%LQR5QN 4B M@=M,9!ZB&GGK_I\B& ;*A!N7>Y7XK1<4\#>X*-Y3YJZ*MH2ET4QR;H!HJK$R M%M ],N1Q,\2%I9D7.$ _;CGYB\=A.$RX53E*PC=._U6RW:-KG^\WKBZ7 ICV M3D;W:UO=+X/.05H!)(9N& HBR8%*HJ(.%, 9%^,>VHTO.A_VX-3D M^XWCA9T$'VAO';3-> M=#N,B0FW(,>+^<8TG&*]&[J:]T-I5TO%,Z%8%@EHCEMFB\N>B;B#MB 9.,BH M$S"*@AUWP[(_X2[DZ\7;6];?+9Z)=X$'3@X>?^A>NB?C3P[^#U!+ P04 M" !", %7YYD#CO9U !R]?7?B2)(W^O_]%'G[;5S/Q0R(=[NGSW';KFIF779OX9J]^]<> M(1*C*2'1DK"+_?1/1*8D!$BVP"!2(N:/'7MS!:N^33Q MF5;3&NR_'/>;^:S+[WW3M_AOX3B__EW^^]>_BY?\.G1&B]]^'9G/S!S]XP>S MT]%XNV$80Z,S; Y'K6%3:[6-=J_6Z6GCGJ;_3_T'^"D\+G_C^0N+_^.'J6F? M3SB^_Z*CS?S+%W/D3R[JM=K//ZP\Y_/O_KENF4_VA9@M?#MV;!]FX<*H\J\; M@^_S1^'7AF,Y[L6/-?&_2_SF?*Q/36MQ\;Z:8_FU9_XO MOZC787'BGR_!:N'7EFGS[\PN M>C!V;-H&,(N[>YJWEFG>=]P<.1[[P[%&(&->A?5MH\J^\)GC^AX;<,.Q1^P_ MY[H+$V,?3<_0+?;?7'>ET'WAWMSRO526K"XU$Q=C/VG "F;Z""=V;O$Q3+D; MTLNT1T"KBW/\9$_TJH7T$N-ZU[$_;16<13^2SVC1,\1H!>:8 MKKM_=YQO8@,+[5WMA58".QO"-\"=<_R "0' 9VK5;B:]W-Z_>1:LKYG(@R^W M@\>'^PK[EUZML*OY$QPSO_Q8;]&VD_9L+NIPYGHE[[L+E%M#^F5\B5<\;XM=@ M%_DF&.2!]P *E>, *(GU3O.2'<0D?97\GF%RV^!,!Z?!Y\;$AK<]+9@%;B=W M*\QW1OJ"N<*Y@%-C;-JZ;QB/30.I =82>N=\5 &I;#0O M^SXS/39=L(EC(QT<0;=P&-.&#TR@44";$3> J$@:6.@Y3H6!AGGQ)Q7V,C&- M"7OA;&;I-HX#;YI97(047DQ_ D+MP1F-9_78,>8>'LP\/,&1=09J<7\""NMI MPD9 >7.&+XAS;*K;^I,8LLH>)Z87C 1_ 27'7<]P7'A^N)#L]%W'?EKG:LAT MW;9!,QKPN) /( Q,3C?@$:"\&,.%'[HC^"-P97".^JH-665_NLX,Z(Z1$F<. M*YO[0)"]"C?&I;MI PA%L'U^\&&?C6,_X:T&BF0YBC'.? M.IZ/,[(L;C_AUS/7&0(Q8<6Z(:>'KX/%^V#]NJ!)\)^V."DK8J;(-/BYR3VA M?+1+8(H^@V%T ZFL^TABW[0-WUH C>#I@.7Z# A5%;*Q*>S90C?-Q-!-'ALD M^8P+H_V-A[59M_QX7NQY:%8LKC]1G+3U MIPG.?NA68RI0+WGS_;1.MCTM^7+]QDR!M38JW48W5\>U)F,W&"0X#)WQJRWI M3?MC&^:5TT!]>0Y M>47UCG8\Z=K55RW2\1#$@ [AFD9C:-N1+'&'J:)@6]66\@HV60RWW0+YT?1G MDKZ,@M"L=DLC"\DK_/E]T<+"&.AA[AB/YX[) /S9[9^#+-'W$S!S3L5LQU1! MY8\5LMO);L]LMU>UYM$-]_!=X]NXXE7OE-O31:Y"IUSRBIJ:^E;;?AS TY;G/5V\ M*B3/*=>K[?;QI*O0-L0V9\1[0JY9#^K7@EY9G2-5M"R60RJO9O?CO:@>Z@"A-T+8RQ'KENH[!R]\\!6>RG9+%C);;R9PF9[&2R9P^TMGI' MM]G7 JWM5^*L^RPY.LJCB:=CO;5K<9#OS(X1-G;HW8 MD,-B;<\<<2QLQ9HA6"46>3+?J;#AW&>VXS/=P^+:^=#S31_.5RQHKH@R4M,6 M9:CB!S/7>89QY"@&EK9B>:JL.\595-GGJ+H6WFN9_!GF(2I%82B/+S$THDD& M0S(=)C'A;O@%E@?+8M*_1>6V\)&SA'+ RJ?EHK$^UY25JZ9M6'/DHZQ?'9J6 MZ2^B8N*%G&W\E\\<_NY[53;@7.['B*H?H\?"B+%\0"Z(<9@#UC%C&?$,OO1@ MKA8\*,C'IHZ[2CY1_2MJ@F%,RY0?XJKFL WAAP;:-5&1>;ALF'D*\:J;MM_? M1;WHL4IG4Z -PNKGL$@^K*-^X6[2@7XXS(E7I\F/ #N N%;-$+)"(5H(C*W\ MR;$_5*]'9H ]@2FPTYS@2Z$P7]1:B,TR%FC)=J#'/0?\ M.?R;FL 8L73+%S@C5P#"<$TQ=U0^@/D@51;[V<93< [C]M*TG\5W6OWG-?Y4 M4/<#A1%UPUI4-U#'Q'OBL&/)Z"-B$]=;ZZ-OCA?4$H/L2/BRI30(_"2,HN"' MK\I;=&3:ZP1K:;O-4\J,G>#W;QXDDO#=FARJL;ED%47K$58@=R+L0Q=X[0H; M9TG]*,%,B(PY15L)@3L0516-C:GY71: N\Z3JT]A7PFH%B TVC@F8J,8DW#; MHH7WPF$_ZVBEC.:&,.-&)I@CL-X9F#)H,@7['HDK-(V]J&Y'NMH/8>^.33\TE0*\,)@W>O-1G.(% M(<[Q48!MD-Z&\VT"T8[&'N>[XN#^*SF\'#AT1#I]5#<+_&.2+2!3:! M.-_%!/#AL>EZ_IJ%UMCR&,]++2;(J A6"?-TZ:8(G-U:7+QG")KF^@MP1OZ: MFS-IX0"I/6?LOV J_DQ?!-Z*1)63X109NPIH@^X+@@D)5H\#[$^EML:4M(F@IZ&,A'_0G> H(^=%S7>0DQ0%5B MGU:K'?<(%4"-KHA?SG2L4K$='_5;?QD$CM >7>[/77N)IJ4 =E/K:7X^(ZL ML9DX%L(TIOBCH!\1>U#X43XNZFENZ6YLPXN]#MH/M/K2X:3P_;E,?-3,X9_"\L9\:&OI-Y_L!FB M3$E2:]V0U,C/@-R_.[HK8NLWPD%U@.$C;E@B\J6O,1$/AUJUT8[588&P#%$O MF2/4- ,^\_ETR-W@A;WHA2!3OF-\"V4*1@H0.X, OV$YGKB+B'SNS>'JK4HJ ML&O&-B6U']3RJ7X/5WO#G[GES&0OEEWDZ$B: PVX88@,[3M@'#M1' M%()R.5[@P#K%<<=2P:.%JM #:Z+"<'V6\\36+X368E.-9E5;]J^ )Z1-\E.W MVHAFA ^.$8-VA H:[["DL1(;#/17M"IQ#GO 'Q>T.^AU 2ZJ@^DS\B0.=$:& MK4)K-]H9@,L/*WR';$NR/98\G*# FS^6H6SVR<+[RM^=T8*=7?_QZ?4<\EH*".@!W]0_P,88H1K5U0A,''V -/8T 61P < [.(T9>BV3T7,$@S0>= TI==9 M.GO/B-&.^@?O7X2XAID>'M?]\V4$!/X=$ _I&TZ#3V>6L^"!O@KG@&:@V&PP M?9=)E2Q2.*:SN2\@S*<.'*<<=Z88,K@=&&".(K!X?X*67O"[ MY:9=;OC($Q! [/BI:8VD?!@SKF4$RBLA$ M,47N3+B)81SP?C'TX4OA@BT,SIH('0%APBP;?0E\/W8\7[P,/I07(\_" #F? MHV2A-G%%3P-2 OM0 E^^](340& RB,V\'8VU[G/^[]GRMM;;G,9DIVO,8"/+U *>: MVQ,A\N*=:%C!AQ5).\>JB$_F2"A? EU?A[M:_+@/.AA>\R2Z=)Q=-_L?F+> M#3#UXAE?TC01<8_X4*X^TMT@"0&42_1#$3 ,-N"S[IH.["S== U7'_O8@\)' M[2W?'_PF>CR('- 1NY?==PN(+)Z,YJ2>'UXY_/1Y&!07BVCN&T1EQ3D(:PF,923+X_+ #8YB M:0+@+0>\"-NDR&07//B>>7#8>_XY#"WS7Y;Y0VD0F2NC R'L4>.-SP6>"&"S]+ M'.=#U]%'5>%\X0DMC8+H:)ZBLP5_2NX%-W3Q,UE<2EAA3H>X&EH,81W@M+DF M7FJ 8R#&U9]UTPIS6*59 (:#_+>:62U)L658N&Z+<(8OX[,VK'5BSJ)E GU# MQ8KADZ6E[( .3"*6_ 8-#&.Y8;,G.!8FNHO1+V2+"">.).=\%&FT]_#R(V[@ MP>RO^D(8/!Y?GLB?UGTW5LX3[*S&UT.D6.$+<#(Q.VN1X(L"4"4**]D+@) M,*7Y(O',0,=6L!(@<4?XXH)W,;P6[@4J<%S\ R1-C"1R\\D!OQVJ6P M",*&6>-/EC/4K7-LOA4]'[MX#?61+^]IU]2, ;M0F&Q/J T$-<)-#9+X^R*: M'LY@.2W1Z@J]=6'N?#?EW68T="665R5TD,O#& (^-YU;OGD^<2,Z6MDJ W7*VZ@U*VLIB?(+W) R-3W-3EI"H>)()3:)0$%0VJ9N- MI-;!TVR\[$.;'UE6NAFRIY"#>AC>W/+Z(4F"\^V4UNU5&YIHRK5UH[1FM=9J MI7Z]:YO:.89$VNA9@?_QL$.51%>^HFILSB@L*U MO;2^4GF=UW/7C5]3EW6=?[JFXVXCI/OMRZ4,':("I[/@ CU3V[L\B'&,XO@Z MIOZHLM@9*-JLD\3*6*:C^67;_C M=RC3+0R/(BQ>]YGC,GWH/'/V4Z>619*+(+"O+DM9U(R/,.(C+G_#&#&.X MR>7;:=72&.GE06&&)2X5^?>9I=LQ')552!)Q4[&*TF*&^:C<\OC+1)0CVS*G M+4 \43+//+AI&#FP! 2YB6[)!-L4*GLH2HDUZ2+R'Y6^![@* M$D 'Z05+'IF8%S:W_(6H/'-@#GI0_20K&&S?'"_$92#L&9$U(?MY+P/]-L(NK6S ] MO',!0OU;PM'8\793"\R26#"\>#=A*3!AS$@6M>J8YV3X<[R\?I9E5P'Q34EZ M$=&#=X3+%C^04@8#F,'=*Q:^.^)"*IP_7GM:5GP5-N=!9K2\DXZEE@4#ANN( MJHX2%B,2MO&>VYQR>8\;$EOF;XMDL.B=N/0A4@ SKF"-X@(%\8HXKJ<"FA&1 MEF12>%"=EO#*-2"((1>W/L&8%EY BM)[W68OR/#@I2;FBLEC:#ELFG2F*8&$ M[9GQ1J.M6&W"M6./<3\9G%VC9,12+Q160;&+1Y$J,#(]8X[E)&F 5B'ZDU#L M2R0(8[EZ U<_Y+ P>;/GLZZ(O-=J[*KZN0J_P?Q 6T@X[K:K^1.(3%"S$I:L M7-FZM?""^B$LIT/T+U-D5P CA(Y\&D!DNP'4OP9(%) MF'H@N+>\[@^/B]E\:)E&=,4/T_GFA>62@3#U \ZP+]P*A.>%#T7FZ-D;]T'C M\9[)(RV^$59-B:E;7,"'2;NVW:Z=M[NMQAN[ MMJZ==YKU5MJN#;([@VSDV(;H*W1[>L/JC4ZCUVJVCU!*O?/IVU/L]+T:.G,_ ME+ZF5WUZJQ\Y;3&7$'&U_;G-,YMLCS]N8LOKF3!)299 -"DWF6RQ-*K*:B!$R1-9B+$E*?!JF=LK$N0CE DN3'.M9^ISP MH37Z&[J4<)IAC90Q0:UA/_&HA'LD,S0K(JDJS/$&F]I\-H6ES29I A'E3&A_AV,/ ?L)"@U%)Z M&%]0G]H5]B^]&BN4#P Z==N>"TLMN(A20]D)=F*.Y R\A>\BC1A<"[P9B8 F M(UB1L>E%V1Q<)&C>@(.)I6HYL[.YXZF93YW"/ -9M)(3QZD/,"W\P#/[X*@VP"\(UFZ6BBX@>L@UN9% MTU\/CXJ2*EW$K$0@+PJ:_?)CHWFY%GL4GZT$?P,\1Y$TSG7A[P?NYY^N^8P^ M^4"6#N"]Q!W\\21_]P7C4U.\M!#HGKU>2^1B>QB. B<678R%,Q=N!6)I8/QQ M(Q :6Q2X$'">CSP9>=0].?N@<+DBIRW^BR>Y/5KY"$/.*Q]@N%,&%%8^#F'# MXY^%]3 K'X:9A_(C89"8P%'=#>8(E)Y-7%QDE7U,7],ZHX)0=P7C@4AFC/() MR-M@"B%@]W@N$K)!VE[\204K#>#;I\5:& ?_M00.@[\(G@K[9EFU%@P5&A*5 MM.A>925\>+8<0,12H["?B*=^6 +3C,5UUEM09I4X0&B,/KJP^''%$0:*+'Z5 MY4V2K7'S:C@?/7$_*M2%R3TY^*IK\:LY_A7,JL"2K+"Y'49ZS< DU+^'X7-, MI<=_6OS)],* KBMY$F#[@+N[")/H [ROD!45,3E1^2$7)T M2TXVQM406P8?%X R8/3-73!=Q98)8=Q0\!%V'J](*@)M!Y^+<,=TXZ^Y*<\O MP3HO/,V\5=X@/1'\583O91%)C/XN'R.6G.0 [HVQK$#RO/ET%HPF;FR"J.\1@N+H!B@*&'W7ZJ$CJ=@K>;D0VT'!S94,D^)*\7X%.P@L ^H! M)!Y6=HV^[+E@@;[RQ=6+3)F.B_%*R5EL=P7.4A3H#_\=[+JX6I$?2;#?0 @]_A4%4'#?I]Z(*JG,)3IP.ND]".[FZJ,02KB/L.8.;EJ"K M!-4)\9.]H")I678O*L> 8#K>T@38=>O3Q9(;WY,#.T,K.$BQACBX/)4 =>>! M_L2I/[FZ"-;ATFR&UW'.U#3P8HX+!Q28V[O#(P[F$%HGS$W\CZT8%Y)Q\6+X\ M&!@>LA!6>O7[)8Y2@%4WX[Z)X4M1EN6%2XS)W_K,XA-RYQ87;'J:6[$;E1F^ M#*,4BM\CW+7\@(@SC76OB0JB;46 ;&D%GA!)+J(JE%Q8?IJHH!'XFMD-2XL"0ZY MD27?# \_K=7:86'E:$7=X$OG$BT-[XK&IC" XC&=Y?M$%2LR0%:X179N[ 61 M)H*-"AIN$.0X2"!PN*X3WK8<,!+'3Y>0!Q2)4*W/ M?1 KTD02@\P8?@@: MHI:M:#E\7!&P4ZF9 @(6Q!2(T#C_E4-&@0%;KXUQ53 M&FP_X;'*$U:4::)NBEF#E9BU&QHXE?2>/8*#>*I$EFFB%.I^ +H"?P2Y+2Z7 M/M8WTT+@EBCJ%Y=!'"5VU8JX2C*""4,Z0_G[H,::&7!TNR@E,D"(/XW&3)Y3 M8#G!I@B] 5&LOC(#_"!V!$7]-0+]C%:VYP"Q\"B1Y>9H=9KN]'QL?N>CAOB8;0VYWY4TCZ/[?KE4U(QBU\Z*^=,3$.: M<)2$]%BK41=EP!$YH_,J^L2? !&$Q2T0$<(3W%L^"K-TY[,5#1B*5;JZ7KF# M NGC(X3 JT@;32S.DO&\HYED4U0\?96%]&)583C$,Z+L@2BK./WK$ M[@*9\=#.E.D<:-3CVV.:*U95+$Z@$*8HINB6>W*D3^$-X6 !-82XQCTNN9V$ MKX@F;:BFX!?BDG_I;,6VN&$%(BK.SS>/%.&M8&0B>&=PLDWU;WQ3?ZV-$\&\ MN.'%HZA^%^Q:A4T3IK W'ZXC.OT;7$2?H>LR=YC@0&X%]S MD*;84'.A6R*I M6"'05=)PAJ6;JT@Y*WL9U2VX=:_26U(V27NM7@IO;N"4%FR1D?+1<3E"N5P[ M+LH_^S,TV3!N50F>^X\J^]TU8JU];"/-7J1S>1\$[Q3-]Q.XGS& MSX;!$$FZ(7'"(;W#=0I<=^&(!OCC,=G#C]#O0QM<-&#TI)-A@F4LTF=XT-]E MC#=KXH2JX"65N*F!7Z[9_<^F$VHM&&8>)J:9:1.1KTQ9!<^<=3 HBW8 M6YB= Q(3!8DBDY;]BD"[U;>C &F';1IL_Z:%V%II: MQBR67CC"[@@#"6O!=4-^'1G+XFW#R&L, (X#VS1A)JL&X]JBO+G(.1G/,:ZR M!.<(3HU1;!GRYQ&M8J>-P"3EJR<;ANB"0]M^.A3TU0CZX0][@+C=EC7.C% M\,@6NR >?$HZQ)?NW$R&-%T^ELG5,E' "D"GI4$H ZMHV.$#^.?JD1Z[C<+7 MWWZ71JC ^ N ;<[$OY'UCS C/ M.C?P7%? 2GE2LI\76J]R:F'N'ZJ\E42$XH3^ZXB"<66M^$Z;-W8BE@B+3LQP M7D*085@46UZ"O AS&#B##3#EX21P5610.;H/$ '=Q5M7 BM=D5#^LC@G*)*%*R$FD/4YSDW:H>-,@,D;,LSTE9AC YX"7SF;32T C& M]Z\$V6+%!2L*Q@UD4Z0@>Q-I3BQ]/WA1D"P>FG])/3M?RPK)&]D%3J!J39Y" MVT*[-+O5=JVS$P;+Z]\UNLV]([N(R?;VB>R2L07Z,2HT'^X?KZX?!^+*;(L* MQ7)FYNGV 'YJBX9$$E>?XT&A6?TP$<3B-WHSTO,LM/A M+ARGG@['-V[F[Z]Y\&%=:_OTZ/BAYWKE_OK[[>]!]O;Q@X #>W M]P/YM\'#7?_F"C\>/,(?GV_O'P?LX2.NY.'SK:)K.1/XSA([IH) #'SFQYH7 M!D $$:I,87SF5JW:[.X&A_J&S]QI[]UGKL-DM8,X^#39@DVVD?[U/D%QMWBT MIP; 4C>3]?LXP;+QSXYH1G*+983[, 4+18*!^3V= &^A_4F-'NCH5=3-VNO MFTF6\+:+?S2GW&/W_(5]<::Z_2XRR-#[?AV!M\B3BECZ!NWR%YT-8T#0#'M. M8[4M&H]X8_$> ./XDD^*M,GBB#VF63VD;!9-LB4+2[M1DI?;J+1Z'1+; HDMZ7=8;J?2:G1(O]-&(?W^^G([E5JOKJC8 M;NW+!.FD2>_N5#LM)>7MVI%8L.Y[/)BUA:?ZR-IVQ$OL0:%?=IN]+LM&B?GIHP)'.E7:DUMS4W]LB:/37.4MNB M&"!@"N(9/8DFZA+601]-3=N4T$V(,(+08]YAXJ69!#>!L(H(;K(6TXKC3BKD M,19<%)*YHK4U8HR*>[39V2=..^W10HA",E>:O>[Q&/.&E1%F6MJ._08OZN]@2K>]T0DE7GH?]1ZW72G,!9BDKJH' M;%\Q%BUPF5(;W6E2])N$Z)VW8MJVQ3;$4F58FE*/ MW:7;HV2 MU97;*-N$^=6+0BAXDMYC^2PEX.XOU% O#,03N13'%Z)D?M8[JB;:$4MW3)8X$Q1YU$J=-99LFU"?.1%S*WG1>\F$EG0[ M6F-M]9&&:9N0;C^VT])L*RJT@4\33B2<=5.(I"K%XUN.$2-: \@R$B@ M25]F+J(% Z#P-\AJF]4WIC7W^>C8Z?P*9C2DVJ2%2=E7*$Y><%E(->>V104B MSN1E"14FC8%DX=!&Q*YY\'1E0V,4?HR\KTY&YG,X=C#$.3Y_T:Q&!K!IC[CM M7YR+CW+5!?\E_L%'3(?IZT^TFG_WH,5Z,8+HU1RAAN?EOM6O M3%]V--*7)R#0IZ,O=P6SW5NRSM\%FE(8U8Q%8J>Z^V3:HFZUMRH.!D<$QX!0 MO_TZQ%'BH='8(,%J.^ \7LX@Y&(1-_4G:] [.1PUGTDXEP&YDV^)7\?_B".;H'S^8G8[&VPW#&!J=87,X M:@V;6JMMM'NU3D\;]S3]?[3N#^&/)I&G/].?^/G0Y?JW@HR$:Q=TT22RSI+WICJ$9BV<9H(IMW=]F\>!NR/A[N;_OVG087U[Z^K6[,D MG[E>/]S?W-X/;F\8_&WP<->_N7J$?_Q^=7=U?WW+!G_Q5&/]N<-!7,]UES[HUYQ\V9@WZ3P"\12FZU)J4W"#H$;PZ^KHJOUA2S_*[3K#8: MW=2O:]7ZCM\UNLV=?OG:9.NU:JO7*M)D>YF&?2-VW. BWW%)!&VK>^XL #?[%:MM,'7R M)7DO6P^:N:W/1Z;/1QNM:'(@S(E$D:\\C_N>4L I!R+6HSGE'KOG+^R+,]7M M=VF#9#^+"+8-P?::Y*ODWA(W-+H-R\._\+_F)EBIH%QW0Q1^XZ;LW5F$A8LT M)BU,Q4AC0R-H@5.0YU.!%FC5M[V7V:-T[1590$F!^0*>!AP40XM[%6R%0_@" M62N7*\T.I:"=G#"DE"Y7&JW:T6N72VS<]NUG,&4==[&[DCK%&IE& =J6JF<, M%EP44E14]XAU;.6WHQ[\"7>9,7==T%-,%W$NLJ4RJJEF2WV?E2RI7+C2[)$= M=4#R/CJ^;NU#3>WQ"$V](%%1:E/LK$JKHWX^]%;T+I -5B@!2FEE4FDW=^S! M>%AVEM]R^]-U9C )\"QGEHY*T1Z)VY/9%%0DQ<2V48,]C2)B)R<*R5SI-K=U M-\F.VRH>YNOVDXG)AM*(H[C8-HJJ2_TJ3D\4DKG2:VU;QT!QL2W(^\EQ1B^F M99$-E5$UM2N=FOK*B:RH7+C2KK1[1RQ++;\=]0"NG^[#7)G%=8\S091S9WP^ M]\BRVD5]M1I-Y94765;Y9&XUC]A#J_R6E;QQM!S[Z=SG[I3N'+>\_>(('][LK$45%#RKO%P=XP[7XQDNADJ:H%"]E6KJ)7KC4I-4U\Q;TMK MQ:L;"K93]E3Z4)2=DH9]6:EU=FRZ>'"YW4LS)<5ZA\2(U@"RC)PYWK[L4%2M MVBS+:X'/Z\OYMQ(3RLKIG!5Z9C8\_:Y2T= M/D5W=%DQ%NI4%WARHI"2IMD[-MQTJ>VOU;K ]WKN>SQH"U7;E884TVVUE-=C M6]&[0)9:H00HK3BPMW4U32[L++]]=[=BN(E44+3GUDP\,NBR)EU5VA09/#UA M2%5K6O$3KQ167NO)[0J9=0H*:4H^>ZNAO+ZB4%H^^>R=;:%I*)2V3:]Z/N8N MMA3U]>^'OCLN^'F:)8(*W>+S]VM7KG4N I^@OJ^Y9;#4;9"99W MW[?,JX[U+@Z&.,?G+^JMG4L>%=L#TK["?1.;B^ M[&9<8:U:$#8(6AXS;Z*[P!M][D\<%]XTJK!ZH[/Z#":\;7P8_-#T/,SIQ4>< MN>_Y\!>\C-!]A@U>Y4\:M0K#%J\5\5C8]W3E.ZW"8+09-[#SNK58Z\Q-[M5; M2@14L':IO-5*WG9.7!'B4'B/6\8'JYV6DC;0% M^;&]< 4%-2UKKJ:I#R5&%QHYU5_5:MN"B:EZIZ&JSOK"?1T^'#&NNS;,FBXS MLJNJ=@' Q,C RDE5-=IEZ;2FJJJZ,HSY=&[I/F@K1S9>@=-T>.)V-AB:'J8]L^[T-D M4T6U-"NM7J/C4%A"IT<&,O;N7]C>R[_99S%J<\BNR[ MXXM1FGW7:.V[^:UB]IVRRC&6("PR,/:F+-^)=1@P=NCXOC.]2( R+AAF^9ZP M/_=(%A4/E(+ _^^=&49S/_TGL4D;'.,D M>;%0$^B/:\F2L?_B',W1/WXP.QV-MQN&,30ZP^9PU!HVM5;;:/=JG9XV[FGZ M_S3J/X0_FD05 C/]B9\/7:Y_.]?'L*P+W7K1%][JXJ>F?1ZG]+9$^NW7(3(Q MOH0CD';CJ!*DO;OMWSP,V!\/=S?]^T^#"NO?7U<5G>O7^ZNO-_W'VQMV_7!_ M#-P==5\=6::I7?M5K5>BO]ZUJUON-W#6VW45^; M;*_:J+=IKJ<^5TW+-.H;GO46I2MO/MK;>#3!"I7*X9!V5[8BEL>)RSG[#,]- M/'9KC_@H@_]=+A(,S._I!'@K(K-B>;YI6QZGG.E=;NG[-LM;]-G&,#^N["2' M$+"TB#5J%30=L; H2_ JRY)/BK3)XOC/N;5@]9"R&LDER:7RV M>C'Y/;6_5BBJGM;31'T ;/5*A8HGSWMJ4JV0/*?<$G6V;\PEQN.;9@6 M%ZU\R,5C#Y.053E@R24JF;MJG)PHIP8[VMNC- MBIKO:EH4 CKX?*A[?"007;CM[6Y,E+N<-$55J=]5@PJ+\]%4V\89B"\Y!31I MAYZ:)*2$ M4%M P3WVW'?H.5].2N3YY"?"AHZ!A&6?7OU"$M.RQ?LY4= H[< MOUPD^JQ#/%%NGW2[Q!/5]DF]T3X*4\H?(A'-1RD>DC4>0L[6J0E"BK-%;%%Q M?ZI_L4*"D M7MD7,5Q0&4:RV $E1UQ/=?N+@F#/=\[@OH;]B4& 5D0_EC!D0 MF1OP/?Q5-_Z:FQ+V1#Z/48T !^4=^5%9[6,:HUQC[!4XN:>DK?Z%&]Q\1M00 MZD:1&5)4?3Q1,@GR"2)L$4(@EN03:ZMKU"M&N7VB-;:(@*IJ.*MY@C_(YE)S MUP7C/6XKRZY3EF,_G?O56U@8(7>5/>;HJR"=/J;8MPB@Q)A]#7/U4 M0I*$?&)S1ZQ+V&>40.L6(SAW91BP(C T9OI"X)2*VBK#<.=\M('7OVZ(Q+ZG MF$-FMZ96)[=&,:USIM4H *#>3ND=Q] (DT.;57^T:V2E*Z8_MCIGB2=YW6=O89 24W+9*$UUZV*S MGO%O':^^,\N5I/>O@-O93TPW?/-Y]Y#Q'JW!HO4S3@,,*@RFES(=2D]8B/:D M!HFCRG TI=A%_6H7DB%E9"BM)^^. &3Y]-M]?XA"PB\=TW[FWIKA1/C M-,9V8Y0?_^5J63 FZL?8<.[!0]ZRNDSX)**NS,W4Y?+4(M%IMVAT.:#8L?S+ MCUVMKEU2_B+M%V))IF!XD>%A,I^UL2[TP1#G^/Q%6W X/W+?F,)B]>U29<0A)616_/M$A9W\/_6%[*TU M=ER\7IS!C!85QL&GGTU%T:P-I';&_HON'J33;<'MXS2798L$'O)9*):OND>1R>E!_[%=-XX(B%:8^"JRA/MZ1'OSO\1+E-0O(02!S( MCU>=+;1+21Q4WJ7E=^-WAY4OMXE;;,U$'D\^$49B"^U2VJ7*B(-RN[2\N;%1 M9='<$XW>$I-CCQV7*%KJ=]J=P!9Y3-NNO$ .2]&XF1(EW1Y'B9AY?&:F]:#; MOK:;N'E\;J9=]&UQ@9$7-W.J3%:@O&9LVKIM[*N\)JNE2V.4:XSRWP;^N7(3 M..)#GYF>-X>]0T Y90L1T!5#+EQI=&O$&!7W:;W2H<90IR<,"N[2\E\%;F89 M&8&9'_UV4$'Y3$4%)[12U93&6;/6(::HME.T2JU! MW8/4VRN-[5,8R&G?N@QWY2X %NQ1BYK2W0B03Y 35PC82P'FI%7_4O$O[9=3 M\Z-O3(3PMT5/.G'FDP.=55^TJ"V.:@IC*[0 XDD^^P3^(*:HME&.Q93R.\]? M^&SN&A/=XR(T[?F.\6W97)U<9W*=R178)8V>O#/%=NA9DWK]*K=-6MH6I6#D M*>^<(1\&Q)=G/#G.6=-O*??VY"0AK0LV\47%':JU:(>>FB0D\QUF.S8LU?9=Q[*P MHM6T?>YRNH_?)I6'/!;%-,P9X6 KMTO(KU=NEQR')2< -7468$U]6&EGGP0; M<6P'/Q451$4Q3KL+;.\1=JJHUG^A&+E7^%QBI8)[4MNF%0DQ4@%&IL7^ZWL$ M#E//A:\5PX6_'8^Y(1I2CQT7OK 9_VY,=/N),U?W.9-_]YAC"P.D(LT0;''U MK%LBZQZ3!="O=TW#!W,$OR,?F&G+OR&X]H&MCU,USO>0+$5.E@)\3(,+H\A'\7B9 M%OEH; ^!08Q4;U.>-6M[!-FFR,<[L+>S&11,]]F0/YFVC5,?)B4(R5[K'Q.L\Q:C'=I8(PA^\ MSP8Y57,\Q3II=I77?.3-*2 ^*19-F[)+"LA,T@4D/J>B"\J/8G''/=DG[3 & M4[F]@)34E'I/>55(#F$N7*EK'6(,[5':HTJ(@H)[M+R%-Z)!*P9B-J,S.41B M,IJ-0\?WG>E% [@W[43]9O/^UH1[^/("IJ^H:FOJ;?(P^. M[+:>SKY+9OPI[KN4!*I&CW9!Z7ST]%XNV$80Z,S; Y'K6%3:[6- M=J_6Z6GCGJ;_3Z/Y0_BCB1O.>Z8_\?.AR_5OY_H8EG6A6R_ZPEM=_-2TS^.4 MWI9(O_TZ1";&EW $TFX<1H*T=[?]FX\,&MY\^W]X_LH<_;[][QX&B,S\S;0:#68CF]6%CCJE2 MLK&*J>X^@3"BKED#-8L6)53%M5-KI7Y= MJ]9W_*[1W6W4UR9;KU7;]09-EB;;KK\2SA'K+18*!^3V= #G*3[T/^\A M60;_.;<6K![23".:D:#E+VB[7G2F$N0-FB@2 M"?W"G[D]YS+%ZJ IY_NBY7M>0),L]B1/L9CUAH^Y[7$VP* 8^NR'R'-\=[*, M(NIL(\"\:T909_L0:7ZKU"KU;H?$8(M[AH*+04I/A$JME&JE-'_H=HE:6RCJ9HND:QM%W6AT3\2@?G1\_2 &]:7;V$T-GY#H[#,P443124F"KK1Z!W&URB0ZI'42#>5* MJT&B0UIGA_5W*K5>8J T?'WP=%?(Q1%MY/>,$>/36HW(NS, :)9EF66Y$3F3 M#XZ'&7=UWQ1=RPUGRMF9Y7C>!R7RGVB, HU!N4B4BT39![_5.RT2@E///:@W M* 'EY#5!(UOI1OF%X)0U@=;93UF%^ELJ11ZM$65G2S>2I6M./.'%?W M.9W@V=L%-VH;36:)7*DB=M;0B%Q;2%=KLX4QD2M=NEIKK;O+:U#OGB3ZSA!? MD7)N#A !+E3.34ILN%$GPS3;K56E,8[20*JI,W_,TE?5N2$:KO*:]U7O/L2:=UR2U\*6&BU61I9 MV*?]5VY92+DIJ79)$Y$F.IHFVK81JKJR+7.]W F%66Z61!0H"OO:B#31T331MI? ZLI"9OOO[[X^ MM#C\.3*??_L5_A/.1":@BJS=MN!]+M/4:C]+PHVX@179IF-? ,&YBT^]ENFW MU?13.7G(=27,GKE!XVOFC-E/6K7>8T/3LN K3 -VN>[Q$1LN6.=GV''3F>[" M/WV'^1/.9J[IN&S!=9?]-===G[M5%K319K"T%W_"7G0/'P-*P )@0/$['4?% MUXW,)Q.L9#9U@+JV^;^"UA5\KS5':19/W^O/"W8/_&"?N,TE/]@M]E&'@6$E M]]Q_<=QO\&:<'_OF1! 5I,UG,N.LYMFEXZUP9 MS'0@;"A-5T_<-A9 P9NK#^R_S!%G'TUNC9#'_S+Y"SO[KX\/__H DN Z:=> ME7T$P<%A KEAFV+I)&>CQX02I+!;K?W,QJXS9>UJ]^=0OC;ELB)8;3OV^:>K MJS^SC=VK-H*QN_BWU+&K[!$^#W^*SWG\"64-ESL&^8;M9/H+L15TWW?-X5SH MNT1F'Y:GL"IS"K-ZQBT]]^![SV-3\[N@3L N&7AGY;S EPR M[9'I<@-F.^,VBD)U-]UW+-6]FIA3!'4M9KRJHGLU#7B6H*%;V33TH_P<5KM@ M(]<$BT",ZZXI;N[R0/TB%4%)7W$7_@3),#PA+U(#7(VFIFUZ?J!1S^ZO!J " MKD;/NFW /&)Z^I/E#&&8OCUVW*E\^I$;$QOH][2(;?RSJ]M/_4&D+"JQ18[X M%-\, S!N Z\X$!4VL3>?"04.BP8"3+EK -T9'A8PL"");7)/Z@"= 8%\_!X$ M&38"$.'%]"?![O9 ]%WOSJ#U26KVJ7$H,X%3GMSRT0Z(CP^_M?@3B,F8P[[S,9B'C_Q4[\0V7R@S#OPPY#N\1:%37*LMHED.!GD6V/A\< 0X4KX'CE"G@U UKFO\ M 2K\-*T>:.; $/?8=6#JLGZ?G?4?!X-K^-L'L?,FL#R8A@5+LL2"IGR$KBIH M(*";+<8&)3X4JUI9XC.<'5-4\$_P 2X%./:- XLFL.1 IX(1^F+:8'GFOQL" M7FUQ<"BD0!AF9ZR=-/77#>+44RQV?-4[8+FOC=I[U827A@MLX QF=B#*2\<3 MA!I'_4GK1CN$_S4WI1VNC_X]]WPQ5/#V_&5$^4-$&E=P= H+P$,9GKONY@F+ MY+M^^%?_YKS> U,+E.S4-#;/ [FNWWX=8O@G1>\&<^AH,,F9XPG+Y<+E%@C3 M,[]\,4?^)(@IQ7\U='S?F5[4EC_1AQX:E^D_B47)#(X&:X[GT@^_]58)$/\O MSM$<_>,'L]/1>+MA&$.C,VP.1ZUA4VNUC7:OUNEIXYZF_T^C\T/XHTF$T##3 MG_CY$/;+MW-]#,NZT*T7?>&M+AY4:S@?3:NV8,KK9$KEU0;'\B+D1I19$/+N MMG_S,&!_/-S=].\_#2JL?W^=;HD<=ZY?[Z^^WO0?;V_8[U?7_W'W\(G]_M_L MR^V?#U\>KWZ_NV6#VT^?;^\?%9W]&>C)0(]Z']2S]7[X[7=0E&" @%Z:@6H2 M+@XJ)N[Y<"*@;:]/08L*A36>^W-P=2-+"O3T3J91R/&7'[M:O7/I16\'A3ETYGY@MN M\"B#;PPXFL^AEJ# M!< I":_VJ^PV(L(PF#V>PNBBP_1A:/$J))$PFZ)5S^W@\^!7R\7'U@5O\^;# M?V.(",^+B6X_<3'05%\@6?7Q&+Z35JD'%'?1P0K7L0PP3IV1.0;;+X@$CI>K MJ@B[ GQ2\/$]03MG)I\* @,@!3831Q,&)*>AAZN@1_+#;Q]7""H,P27[,"HA MA/9K=5!E3WCTVL)&69-I*7H@< ML^G,/3"48G(OS7\@WYXQLF=]QO!_.(FY%P00H@A-*-Q>^C[=7%TE6!I* ME#1(IF!ZF#,PY(*MC%8C/";%7CY\Q\V1XR$9G"$H33$T""A8INBV5%;H\2HY M8L104:+NT_=KG,;K>G E "@5(-#0AN\#@SB@K @3O29G$[ &;<>' <#\7I$X M9/W<#C1P.;Y4%7QE1#D"\M1T1H$^D-.>@>:S1&C.4@>$$(J MY:GNH?VN@R-*HZ[O@[DQC?'-]5$!&)C\T8E MBS20MUTF&L,@J>'T'8R)@4\%!+06(96'S@C]:/3DER.2 L*OA:!](;YDSNN>4ZE-P_CTG*9QS) MG[RU1-:-Q'D7;"AX5%SN(($LRWGQ5B&37E_?99(I)QW3R*,1V%6P?PB M_,OER/1FEKZX,&VQ$O&CRV#TP UJ;8+CB/?)KP-3OP>>=ZN!UGZ0B1F\.' $ MJL(16$M$D-]IK6J]UDG]NE:M[_A=H]O:Z9>O3;9>J[;K#9HL398F>[C)=C,- M^T;>]Q;09&\^6F]M/)N0 "95[R'SHWJ94N7^"28-:]0J3*MIC0QIJW:I^G?CW 0$:K]\'26-)D)I39W'F=D232F\R2&_KF,DM/JZ^! M+T34VF?QS7'FO;EMX0GM#]H?*5 ,C4JK5AAH:-H@M$'RWB#=2I-.$-H@ M[VMJ5(H-DH*H5VFTZB2M)*V%D%:P=]KM'9L1D+B2N.8.556IU;=%+,U%7,N+ M*47 \MO8QUJEWE#?/-X/?@<)PUNP/I5.7?U@ @E#+L+0JW2;I!E.3AA2&FM7 M:EM[B<2:7%C3A7UZ'#PL8LU;YG^MTNUUCL<;ZAYPO1UJ.MESN]-^2K/ MUDMI75-I-7>\1Z5]0/N@-/M ZU3J7=H(M!%.?2. +=;1MFUGJ\!&4+0G61 T M7 .C0[P@2>(0-*B"W\2!U1%31SX2 .N$4*OP]4_M>BV"1(\CW1E_S4WQ^PFP MYVF"$(!A>Q 8>QC@\8?XD$E=Q1#X7\+82>2;)?3^J2)]+Q-0WP/UW:S]\!M! M?1<1ZOO^X5ZV1/C8O[^ZO^Y?W;'/MU>#KU]N!RJ"80:@N7,O@/9T89.[ B#; M<9]TVS1"Y,]*>LNBQ*_DFBI!XP7L$O5[__'F:N.#Z,%HC)&)VQN^_W,0^W3L M6\K':?6/O.<&QL_R/:&4GHVA!.="$7NA:A1@R#"EBGC,Q=/)6E0" M:.7HI=[$F5NC #L79^F9\#()P&N"4I/:UG$E:JLW'WJ^Z0,IHNXA4N$+?2O6 M'8V,U A&%[CFNA@3WO#ON6V(404>K63VWP2 N#A/!0+JDA">#Q_(9E$SE\NS M!<:1:Q+D$4YF4/2*"#98+D!A#IDA.1P$2$P_98V,E0MR6T;X2? MK(>0O4AWV?G"DTCD07?* DWHAVV]C#76UN:/N+ 2Z!WV;AL9LE>9"N_A VF M(WXY=C])G*8N<)GY7W.8&0PP#WK^+,> =5L+;-DAT++QU<'&QDGB+&8Q6IV)*21Q,'\/1,XI;LP Q!,"^80_41: G)6DI*QEFS^9.XQ M"WXK=@]\:[JXA !97+Y T.C(<,')JOUA50]Z1V@<8^@S@;(L93% \$:Q-E$# M(8#SLJV-;'FU0$I'QIQL'! 0'YO""3#NL30 I5DE)04HSH72D6(PXO&^>6WC>B0XNMK?\*OY=9(&(KY[A%;C'L+.O:/X8_R6>;F?PQ+J^ M%&/9PM4?85-2D):B[,)U.9%3.;XU&6W!]4B/ZALO4FLV]Q6US=?VD&5Z_K)[ M7:K&0^&7;G=DT.G? S]0<5;$@H''Y\7R<(D$A.F^[YK#N1_&2(*X"W9 PWC M^8[Q;>)8V PI%OH, WIOJ\20=TF+ MY5<[[61I4BRYEDB'UW1')@D0\WQS>F)'!_/:K05S3)QZD3AEZMK<:I;\+K>> M?I=+U[)EN98%#[U7O[Q^N'_LWW^]O8%_-=+[^JG3D[D2M)9D3Z[SXD\P]HTS M F',UJZYEW=BRXKO*-782B@+^[#:AFF9D7,6[]?LK%_#"&]B/?]$FDLBA69Y M4Y>Y4V,OJ?T&$*DHG1K;6K56*U0C.9KLH2;;SC1LCBWZ>D5J4?K.8M[8;(4XBBYODL-I:<&84A]WB0M,6U MP%O32+AO0;/NO%%-""X.=8_C #_\=E9?"PH3+-Y;=D)7>2.! !)SXDI7JVN7 MY6'.KF.4UR]<+_(Y(FIC(6 1]@M1I3;P0:H;V>HI?T)L16?%'?MA[>]>[IW]J=4S)=_K:B4M3$6'JE=3'])7O9A.\>1Y3UW5%9+GE+Z6 M+>IW4PI79C]L4?1.+DQ:MQW[#>$YC2>)7+N0ZWWN M&H-B,I2G2GFJKZZHTRS,]:)"US+%D^=3R5)M=[N%EZYM+OT*XP]OVS%Y/VRA M"SP:@XS%O5@*LF7(0PSO(&D_*^$VTACEHU*JT>W>DIZ,<=ABZ*W>OLR9JG2+N]*NW('( I;:4>AJ)RXLDNEG<+,(;_P M()5V[S2@BU1)M"=GL1"51*ENY+*IJK(GQ+8 8"H[F$7:'WMR/0NQ/_;NE!9" M6K=Q5TM0:==6C)5'=7&S=&AO; !9I]I:.\Z_FPG@&AP_=AUTI92-*.--\Y; MU2X?6]R(=QQ_'R757V,6@P MX@L^Y8"V%CR@E@,G N,/*D,V\\ > M97/1R-,>A7WU,H'[IRTJN9?'D;'_O1#\/P7[_[5N\U%3E,IJL_C-7O- P>1^ M\]A2 %\\=3P?!H'W8V/MU ;KXVWT:7*_@==YD6^+ 5 !U9I4 ]OV&&C5JEI] M-\SZMY#PFSO]\@TD_%:/)DN3K=;;V8;-$8-?JZO1$6'=NDU),MKHB,!"Z'VV M@;M/G0QVH/#5=GDRVT%Z[SJ($O1Z\Y(P4Z]T(FH6HK[=D9P(F64W1YT201+G MUIKT[;V]Q!M$420J^[!FRBMU]Z-F>/O0US^*1;A3;H :]<+?_R@65"_9-CGT M+9!BVR2?FP,261+90V.QU$EF"R2S9(V@-=)5/U\QKVV2=U%=[+8C&.(.W+WE307_/L/[5'%50BV$=MA_4^!T 5,=H-XHIKJZO1.(A23XYU'5(=Q4+3TLI5]IH10J,9=/?%15(*2F=E4U%$B MANY:V+\M8#9Q5!F.IBCY5F%ZW)4E?O+F%15"?Q\W@'+'/4_4C,8J6YGN^ZXY MG,NZ4-\1]; &#.4ZEB4SZ'V.12X4P-@N@JG\_B-WD-(FB#G$' 680RJ4$FDV M@ST;ILD=-T>.0/:9.C;,QC&^31P+K,<#YMA08GWY$NNU6D=YU5(P%[MDVX1J MILH?YR.1+9_(ECV263*9)6L$K9$"]%_-.58;3B2<K55F*2; EF[ MZ@GTJ?0GK%5K#1(O$J^#B9>VHR-/XD7'<8;CN'M2QW$9.M*_[BV(?@:[M7@[ MQ9OU>@':95.212YX_ M"*>X',4Z@AR$CF4#!G!Q?-1ZK;HC>DW&U>^@ M_/);_<_'CLJ5%B:;MN.NV[%'VS%VBF7!,VKOJ[;F3< "35PQU3^P:]TRYI:\ M!X6-I\B<#S^W'=\W5H.PC>G,IH+E'FQ#>"K M="(&ZVHU8>&;U4@1,M7/JY5< :Y5;?D3?0AF(:P\]2<;G3,]"=^/G2Y_NU<'\,4+W3K15]XJPN9@LP%8VN:*-1:7[)O7^ZNO-_W' MVQMV_W O=\''_OW5_77_ZHY]OKT:?/UR.V"__-BK7UX_W#_V[[_>WL"_&I>* MKN?,M!D,9L%6\BJ,?SM%)8%ZI H>-<;CBV85IFE+84Z3L'U@Z?BH;>6()2B?4 MK[#1LNM&)="O^"_A%E4$!=<^#"D:*->IXX%Q8,+[47.C0M== 00HWCWENC>' M:0J5+G2QP.":.@*#BP<87-9"FBAU@<.EB4;E*>1.8T5AP <;G6JO42#4N4)! MY-%D2SO9!.;XY#9$K;>S$35/1,>.FHB.R?Y=(J(C'$/!0:(P MH*-:^&\IB="$YDAHCDVCV@WUNNB*"8H"O])0?\90\KA81V)YJ_6/!$.]SY8A M2DNLII4\Z'IZ+"6&EHVA)8\QGQY'*0*KUI,G(WA:KZ:HZ%&OLE6+EWJ5G4#0 MX:S5H!"J:CS9 C*76)(32UK$$^5X4@J6E,%"+9SH=&HG$255UL2\CTJHV3L, M-O+JU^%J.MNV4RVJ7W\R+&T20TO&4-JB)>/HJ3"T#)9JN01/._%8ZIN&;ET[ MMJ5[QSU/(/+$8(.8[ONN.9Q+U!W?$6!#!@SE.I8E*RUEQQH*9FYG_I8G=ZI, M;"E=8ALQAYA#S*%@9S&$Z(BG(L4[-^.=Z[;?'3='CL#RG3HVS,8QODT<"\QS M[W"1T9W]@Q.L^E._Y*^^=Z0-E<(/)*MEDM5]A[-)4DE2"Q*G)U$E42W&!81* MDJJ(0W@X+ W:42KNJ/JV;7]RV5.!/QW.(IQR2^R8P\5JCM3,BJ9(4SS!V.,! M2$EQN$"OWRS;M>P0B-O#/ ];_J*]I_SEG2Y#:E7;,:RBD)U/XJ6J M>-6JM1VKA4F\2+PRB%=CQ^L+$B\2KRS:J_CBI9QGLF,0C+;!\6S$UHX1K2*F M ^?O4(K.J;LA@IUB8EN]T2U/4ALQAAA#C"'&E( QBMN7)$ 'R=#]NXB!_[;9 MT3WH[8VQY[:\8Z0^X25M$$V3IRV5(FPDV@Z#UZJT'I=^I#@A%;7F'+MHTSB2^T7?[;D^M9&SB1%BY[\;4Q,NC\7+?+:F5 M9*4J5M5[[*]2G:B]H\3.CE&IR&,-Q5(7%J=8P>52JZ@%084*A-SSEJ=[%W=B2>T M84X\@%.@(RH0HQ,)U?2#]J]AF*:"O6,I5I/=H*E1K.94/4YB#C&'F$.QFH*> M5>6-U=S^WG^\N5*J4O/$BQR*4^'0:'65$IQ"R\[^5JVBJ.P[N4NQ1!(2V?*) M[+MB9"2X)+AER=A33&25\W>H]>BIVK_M=][H%R;T+;U$)L&"CQW%S=!F4?DP M5;U6K>T6H\JX^AV4='ZK__G8MR;I1(S34=W6K#3+XY_O.SQY.LIM6ZR9TBJW M+9'\]S#--[$R-9&54__ KG7+F%LR36_N<8_I-N.>;TYUT3O)U_VY[[@+@=3A MPF<,GK-#C$U]].^YYR.6JE==!<508WW:!W:KNS:(C,=FW)6MH)@I.@G/1',H MQ#^9<0&"8BW8V'$9UXT))BSZ$YZT4#9SN8=8IR,!:@Q/N;*B=JHOX'E8V'R* M+8OQY[[CZ]9R$+XYE=%<]#<6VP"^VB,&RMN"*DBT)=M^^W6(HDP_*?M/ B%I M-4&*-G%RHAX@($'Q7P4=1&K+G^A#<.I@IZ7^9 -"."\]+<2_WES#\HG]=^*& MZ-:+OO!6%S(%"@=C:YJ $%I?KC>/.]>O]U=>;_N/M#;M_N)=:]V/_ M_NK^NG]UQS[?7@V^?KD=L%]^[-4OKQ_N'_OW7V]OX%^-2T775K!/RW)"/<&R.'_@DB+,]S M_)<(:E0$!=<^#"D:'.93QP-CU(3WHZ6 !H3NBI9+XMU3KGMSF*8P(?!QS_P. M/Q%M.7C0EL/FTB!NU$1SCL8O/[:ZFX+W6W$Z.35[U4ZGD_HUM?"AR:HXV79- MRS1LGDV'ZAO/)OCV^3<=VCB5A*(8@&Y;:SEDHY]"[B4L^AS$X^]1RB MGD/*$#)Y-^?;CN8-HBARD?BP9J=3_N#VWF&Y76?U>BL[9(S"M;O%9,J)%%835>M*WLR9^A_L?<^ MUWNIAW8(90[ M[GFB,#16O,ITWW?-X5P6AOJ.*'DU8"C7L2R91R^[4E (8[L8IO+[C_Q!2IT@ MYA!S%& .J5#*I=D,]FR8)G?<'#D"8&OJV# ;Q_@V<2RP'@^89D/9]>7+KF^T M>\JKEH*YV"7;)E0Y5?XX'XEL"46VY)',DLDL62,B5JN1-;+J!843":?<$IM@ MW[[R*>*7TRS5G"6Y_X%BNEE":>[@_^]AGH=-!=7>DPKZ3N.@M.>_\D>\5FT7 MYCZV0-:N>@*])R=,(8%.7E&M6MNQXR:)%XE7!O%JD7C1<7RP^']5*PR\3A$S MH/+W%D3+@DRHL72SCC6S#?7EGY(L/M1E MAGJAT&2IRPQUF:$N,V]Z9"?4QX.ZS.1'5.HR4\0N,P6(.1T6C> T,[PR.8K; M4J"C1A?W-V$8E! ?!67GT!FM*EU4Y).!7:3KL8(I.DJ_IO3KHLDL'8%*()Q%!^'<4B;"3:#J34>M0U?J&7>&1I=U2K)E6Q-:8;Z43+DTVGL)):D? M,,K0'62/-NK^PW"*"U*L+BGZ+=<,H M>S8OG[G<,.6=W9I_21;5FX+2;I"W1KAOQ!SEF%-J-5->OVT]A63+S)%#&C8% M$A>P1H_MGI5<\ZE7^EA*YIR!)&=O[*(P4\JE7X(]?[RYHEQ6=5*MBI-GU6GMEF!R6FEZ ME%IZ@/M)Q6ZU2&3+)[+OBN:47G 5E%HZI).3^M^9J%68X(HT99F$H#AVF" = M1+@X3FJ]5JWMYJ%F7/T.RB^_U?]\[+A<:=&R:3ONNAUW3%,OWW9,AC4*9Q*@ M$.%ZV_LJL7D3MT"3MTP?V+5N&7-+WCO//>XQW6;<\\VI+K .?=V?^XZ[$&4X M+GS&X#D[+-/71_^>>_Z4V[Y7W8!F4F!]V@=VJ[LVB(S'9MR5T(W,%+#N,P'F MB,5-,RXJG*P%&SLNX[HQP1MX?\*3%LIF+O<0+F$D(#/@*5?F6D_U!3P/"YM/ M$3\>?^X[OFXM!^&;4QG-!=B\V ;PU99$3(;$HI_03Z)V)JTF[)3-*K8(S.SG MU0K JMMOR)/@0_ K9*ZD\V8$3R4K1BB]=;JQ2(_W<2]7:9Z4_\?.AR_=NY M/H8I7NC6B[[P5AYL/N'>ZDV/_;OK^ZO^U=W[//M MU>#KE]L!^^7'7OWR^N'^L7__]?8&_M6X5'0]9Z;-8# +MI)78?R[P<%L6>I_ M?0J:W_?$42)E!K_$>8+$>A^V7E0:2&)^&_(1SKVQ8UG."V)("9O'"\],<2BZ MW'!LP[3,*-! QG\)/[HB*+CV84C1 MX#2>.AY8DR:\'X]ZM !T5V!'BG=/N>[-89K"!L#'/?,[_$3 MO$ MLU:2(NV M+J#;--'>/H78A4>K;'2JS5X[]6OE8 H+A:E(DZ7)"FC-;,/F":W941-:,]G- M3H#6!-4>J&="UGP?J"$A:Q*RYM&)2LB:^]K-'IK28/.:K@AC&>!_/!'QLJ%P MY@I+^@91%+F_?%CSU2BWBA)5LBRWU=SV6NA4DE1(:)45VFV[XY#(DL@>^_Z] MOF-72Q):$MIC+7??6$(DLB2R!UYNNZVJ<9!W[JRR0,+HOB^O%A.+F0^'TENF M.M"S7BL[*('"Y9]EXDGI:G.).<0<8LZI,^=81TUY:^>/A R]SSX>2DMLL[GO M#DJ*>:^GQU)5/3MB* 5%B:4G$3(\/8:V.JJRE#ISK9J2U)GK)!RQ+L7\5..) M1BQ1CB4]XHEJ/*D32Y1C2:-V$G$]96VW^ZBBDKW#$B*O9=T-;98<-/#T6%KR M_N*GQ] N<;1D'"UY*<%>&%H<;C:;2O:25"6/KJX=VW:\XYXG0"]BN!Q,]WW7 M',XEL(7O"#0/ X9R':^@Q\J M.(\HDJB2JQ0B5ET)23U-8"R&OS>:VW7QR3@,.)Q+. MNB5$G[[[0B2FLH M*&\+:-5=L^L*9*22>!UK1;5JK4GB1>)U,/%J[YC71.)%XI5%>]5)O$B\#G5Q M6*WOB&M2Q-S+_#TUT0=N-PB>4TQ4J3>V]00H@X@80XPAQA!CB#$%8$QRKWAJ M*DK=)&FR-%EJ*OH>_4]-18_=28^:BFY)+VHJ>@"B4E-1:BIZ=.+EVU2T?*DN MN0 9[2W9L%"7%IF\^FTIT-G>(<[QEJ/9HP:VE)A,L% DLB44V;(#7Y',ED]F M2P[M=9HB>WJ&9;/9>)]CMUM""_40*'H/@2UE(MP$BEZI]KJ4X72@@X^2 O)A M"R5K*,F7;7.?%69+N51^O5';2TA;_53>(W76W-MU@.*"U&QVE.U06AP]N>]> MEBHYTR?&ROUWL21F'N_FZ118>2I'5:MSE&C/,:F$/,(>;0&5#R^,AZONV6:;:'M#H+)"[U>OO889"2:S[U8#%*R9RS M>KV5O0$3&'F$/,H3-@ M[0PH;USA]O?^X\V54G5;)YZ:79R\[$Z]H93@%%IVREV)LN_,&<4NZ4EDRR>R M[XKFD."2X)8E&ZHL(EM<>3TUNU)KGDBH5GI?3 )('COJF*&ME?)AE7JMNF,Q M2\;5[Z#\\EO]S\>.\N_0=HQFJ>XL3T=I[%@P6CZED0R=',XD0#K&];;W5>O^ M)M*;)A,>/K!KW3+FEDR!FGO<8[K-N.>;4UTT@?!U?^X[[D+4P[OP&8/G[! A M3A_]>^[YB+#G53?@GQ58G_:!W>JN#2+CL1EW94\+9HI>@S/1Y0)1!F9<0 U8 M"S9V7,9U8X+)8/Z$)RV4S5SN(5+?2$!=PE.N+*^;Z@MX'A8VGV)30_RY[_BZ MM1R$;TYE-!<=$,4V@*_2B1BLJ]6$A6^B T3XUS^O(BL$Z-FUY4_T(1BOL/+4 MGVP $N:U;P3'8JED$L$@]M])U-EVIC_Q\Z'+]6_G^ABF>*%;+_K"6UW(%&0N M&%O3!'#"^I)3LP/_:EPJNIXSTV8PF 5;R:LP_MW@< I)Z(T\D)M)M25RPW'-DS+C!)B(]7EP.+@4_A=4$4\7 1XR1+A MGS\)W8@:\=IQX7,\*4"QK?_NEQ];W73>;A"G,/T#FNUJL[X;:GK^6.S=:KLP MN/'=:K>YZWQHKN69:S?3J-0Z8//9 MG4S>A_7C\'=M1)(#^B4B>!_>SL^U0+F+;X>XB8<#NS]]8" M;U!'D>NJ&S[&@@(VP+@,^I64_K6]M5%X"5(Q3R69 MV@EY*J7,";TVGTWKV+F@A=F#;?65N,)%N\64A-*#V)>*+1WBBXJ*LZN1XB1) MD&9L_41$H3#&:F'@(_[@NN5/"%,QZSV(IK[651B/KIBB<")@@65BSHZ]08@M MAU:?'5*?) K2K:S63D06"F.U%B?$&M9]4)@UHV2<-6K9X:;);U?22"&V*&S8 M$W/RT6/:%K#Y"O/D?<=PCMP0XUR8/KS#R))^_?E$ F>/6&]_Q/3IH-@T 5GD MI'.9]D$6%?5>HZ%^C'_OG"A&TF!I=N)^,V'_;WOGOILV$L7A5QFIVBHK)1:V MN;F55HJ2["ZKE%2;Y@$<.A2KQF9MIREOOV-#"H&QXAOFS/#[)ULGS1R2RY=(+> W*(E5""W&A)D'/.$C>8+UXLR MJNS53.3 $%XAX8%7=A@A@E<&7AF5>@7Y==>1U@Y)IR&I%[@-(25TRO;T@&]M**7OG&<#GEE,E]EFF5!F2LW MBUL5F\P4?8I71C%@OA%63EE.,=32SG,\U$)1+::-.8:F8ARC[$,\74S=B2_X M E-74F)GMJ4%WDDGG0!31U(M6%*$T7%>@K< FZAL5O4VZD-KX!7:.D55:N) MVOA%F5JD=M1)N5$X-=M:]$% %BZ#[B$@-6$]=ON&U1_F_IL>CTXE=A[&BK$6 M\ZT6T7_6@"8_44[CO?=^[M(3 \[L3H9/M(%/K"5:V+VH4#[A)2RN[Y-T$&"P8KD:&VP/@ M526;14Z2YB1#U4[A(N\F%HP6H1TV=Y)Q5A/44BFH!<(R$/:>ORM.2-AR"4_-$\#D*H1C@%? *>,7>3BX5 27P"^1M M!]Z=8HMVQ*K"I9H]8M7+2%X#IOKB^NN_I#*P M,]M?74N&MBIQ$6486';/&'2M0IP>&DPAE?A'&"O&JM)8G4)7;9,UM?]:$KPN M^2PMX77Y2V9FN"ZKS&+^2>.ZY+(%K@NX+EI"!:ZK(4'&,4_8:+YPO6@NQL2N M9B(#AO *"0^LL\,($:PSL,ZH%#K(K]?F'>QEZ4WY@-'J9[0@C\%PE33,83DC;9"W5^9LGY.!Y%!\&FEO=L_F79'0.7* M. 508B3U@KXZPLHI?>@D] *G.77EF&;9C!J*:44Q ^,X.8 RJ:\R;;8 U)4K M7W6[P!U15 QP<8258\)I2.JE8DLAU'+@2:8/O"))Q9B.4;&@>BIYKSI+OB#< ME9386:^G!1E*)YV <$=2+5A4A'*@G$J33'>@Q22C/GXPIRD"^$%@;(!W:EP> MO6Z]C4;J0V7@%_"+^@\X\ IXA?Y>89KU^CK@%_ +'?T"B$QX!;QBKPFP?^I9 M5)EBI'; RAS*ME%Q3X9V^,C"=="Z^,B: Q^67[*S5DMV[(*-PX1]XFX@9#]] MVJQK[=[)^HV]KOBL1;B"0WV(N.\FW@^^P4J*JVZ_:WWCGQK!PO_&+QXB[WR_WV9G1]=\_^OKN]'HW_NC]GH_&5D6M* MQQWKP_CRX7KTY>::C>_&*XS/GZ/QY?AJ='G+/MUW//WK]SS(]7=^,O MH_'#S;7XS?Y(]'[.O(")B_DI:N><\9\3+H+G@D?I4(29;B&=BHY;#K-MTPN_ MS#B;AKX?/J=LI14;=Q'Q6(PR9HGX9\0G83#Q?.\73BUX83)-(\[9Q(UG;"K> MSY*0!3Q9_6$1A3^\E+/XN-Q"-[D3$<)$<.(QN8U9)4!6S:O\-HC%.Z2DY5SU?YX"SNQ. MAJ^UZVR>:X8PJ+B,Y=9W<=$\H,'S&OI9XO_6V"1/5*E"+FQ#,G4_NC%/+R!2/W,GN2/!H2&X&MCL M@3EOW3+%,R_,OFJGD+P=D1183U?".PZ-:*+D'?)[[38-PVO$5/5ML?CL+N?9 ML_PTC-+96,S!R?*<\?^>O$6&]$X?J^-PFCR[$=HPBL;XLVY'BQVR:NHD9]>R M=9Q#T_7=?CN6K[:1HHP3G.21 IL64F!X!U+@/'P)15-=3V,[16BSMZJ/'*\S MIZ'UQYT]$LH.L>UL@_02X_H\'3=)(N_Q:57$2T)VR[VO82S$,Y^'@1A-./D^ M"WTAYOAX:WCT G%#:0JA<"N_(ZLS4"4942CEH&?/#246A.PYI^]@<$0P3=L+ M9>WMAJEU'"/Y\I55IWRE]VJ2?-:@_P"+9<5V"A;'4\L1DH^P]+)RQ2TA)\)6I"X@GWT[Q&8'.'N; YPGKP]PUCNLZIVNR,/J M&JQ%/K8B>VVGUD V>WUII@C"X U-TGOEZ=Z:#KL9@EJ5 Y1UL>DAIZSKD)]U ML>F!4D32TSMR$A'3H6BKV/6@Q!"5SDJRZQ2GN]Y)>I]W^YMQ5%3!27F@S)Q, M$,HB%^EO,+["1\AH8PK:GU-2,DCG;(UO)E#KO5 ECRJ]#OE W>K")XV1?YP_:Q=\M>&+V^2B.MG__>"XH"C?";7$>5K M_+^%!)9\" 60A"B\9_26YE&X7R#6-HLD^;?RZF@ZH8[5 5 " 8H3 M !L9&]S+3(P,C,P.# Q7VQA8BYX;6Q02P$"% ,4 " !", %7F>,E^ZL& M #I, %0 @ $Q'@ ;&1O&UL M4$L! A0#% @ 0C !5^>9 X[V=0 7*,) !X ( !#R4 M &QD;W,P-C,P,C-Q,G!R97-S